{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:01:55Z","timestamp":1793307715492,"version":"4.5.0"},"reference-count":466,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMDR\/SG\/11\/2024-01-05510"],"award-info":[{"award-number":["EMDR\/SG\/11\/2024-01-05510"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["R 11013\/52\/2021-GIA\/HR"],"award-info":[{"award-number":["R 11013\/52\/2021-GIA\/HR"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/3\/8\/29\/ITR-F\/2022-ITR"],"award-info":[{"award-number":["5\/3\/8\/29\/ITR-F\/2022-ITR"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["33\/20\/2019-TF\/Rare\/BMS"],"award-info":[{"award-number":["33\/20\/2019-TF\/Rare\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021508","name":"Department of Human Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021508","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Government of India Department of Biotechnology","doi-asserted-by":"publisher","award":["BT\/PR50892\/BIC\/101\/1279\/2023"],"award-info":[{"award-number":["BT\/PR50892\/BIC\/101\/1279\/2023"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Government of India Department of Biotechnology","doi-asserted-by":"publisher","award":["BT\/RLF\/Re-entry\/42\/2016"],"award-info":[{"award-number":["BT\/RLF\/Re-entry\/42\/2016"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.arr.2026.103070","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:58:59Z","timestamp":1772096339000},"page":"103070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["An update on the monogenic causes of Parkinson\u2019s disease: Impact on patient stratification and personalised medicine"],"prefix":"10.1016","volume":"118","author":[{"given":"Sakeena","family":"Asmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha Mary","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimna","family":"Mohamed Ameer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Nidhish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen Chandra","family":"Sreetama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TR","family":"Keerthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh A.","family":"Shenoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SG S.","family":"Chakravarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutam","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.arr.2026.103070_bib1","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/mds.23265","article-title":"Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson\u2019s disease","volume":"25","author":"Aasly","year":"2010","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/hmg\/8.4.567","article-title":"A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson\u2019s Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson\u2019s Disease","volume":"8","author":"Abbas","year":"1999","journal-title":"Human Molecular Genetics"},{"issue":"13","key":"10.1016\/j.arr.2026.103070_bib3","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/mds.25160","article-title":"Imaging striatal dopaminergic function in phospholipase A2 group VI-related parkinsonism","volume":"27","author":"Agarwal","year":"2012","journal-title":"Movement Disorders"},{"key":"10.1016\/j.arr.2026.103070_bib4","article-title":"Unlocking the potential of lumateperone and novel anti-psychotics for schizophrenia","author":"Ahmad","year":"2025","journal-title":"BioImpacts: BI, 15, 30259"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jnc.14808","article-title":"\u03b1-synuclein oligomers and fibrils: A spectrum of species, a spectrum of toxicities","volume":"150","author":"Alam","year":"2019","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib6","article-title":"SCARB2 variants and glucocerebrosidase activity in Parkinson\u2019s disease","volume":"2","author":"Alcalay","year":"2016","journal-title":"Npj Parkinson\u2019s Disease"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00415-024-12770-x","article-title":"An update on immune-based alpha-synuclein trials in Parkinson\u2019s disease","volume":"272","author":"Alfaidi","year":"2024","journal-title":"Journal of Neurology"},{"issue":"24","key":"10.1016\/j.arr.2026.103070_bib8","doi-asserted-by":"crossref","first-page":"16184","DOI":"10.3390\/ijms232416184","article-title":"Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson\u2019s Disease","volume":"23","author":"Al-Nusaif","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.arr.2026.103070_bib9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.nbd.2015.06.008","article-title":"Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson\u2019s disease cells","volume":"82","author":"Ambrosi","year":"2015","journal-title":"Neurobiology of Disease"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13760-012-0015-3","article-title":"Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson\u2019s disease","volume":"112","author":"Andican","year":"2012","journal-title":"Acta Neurologica Belgica"},{"issue":"11","key":"10.1016\/j.arr.2026.103070_bib11","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/mds.25145","article-title":"VPS35 mutation in Japanese patients with typical Parkinson\u2019s disease","volume":"27","author":"Ando","year":"2012","journal-title":"Movement Disorders"},{"issue":"9","key":"10.1016\/j.arr.2026.103070_bib12","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1242\/jcs.180737","article-title":"Ca2+ is a key factor in \u03b1-synuclein-induced neurotoxicity","volume":"129","author":"Angelova","year":"2016","journal-title":"Journal of Cell Science"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib13","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/mds.25421","article-title":"Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson\u2019s disease","volume":"28","author":"Appel-Cresswell","year":"2013","journal-title":"Movement Disorders"},{"issue":"17","key":"10.1016\/j.arr.2026.103070_bib14","doi-asserted-by":"crossref","first-page":"9241","DOI":"10.3390\/ijms22179241","article-title":"Understanding the Potential of Genome Editing in Parkinson\u2019s Disease","volume":"22","author":"Arango","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib15","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.stemcr.2017.08.026","article-title":"FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson\u2019s Disease Modeling","volume":"9","author":"Arias-Fuenzalida","year":"2017","journal-title":"Stem Cell Reports"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib16","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1038\/s41467-024-48997-5","article-title":"Structural basis of substrate recognition and allosteric activation of the proapoptotic mitochondrial HtrA2 protease","volume":"15","author":"Aspholm","year":"2024","journal-title":"Nature Communications"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib17","first-page":"879","article-title":"Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"The American Journal of Pathology"},{"issue":"9","key":"10.1016\/j.arr.2026.103070_bib18","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.neuron.2023.02.001","article-title":"EndophilinA-dependent coupling between activity-induced calcium influx and synaptic autophagy is disrupted by a Parkinson-risk mutation","volume":"111","author":"Bademosi","year":"2023","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib19","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/acn3.51781","article-title":"PLA2G6-associated late-onset parkinsonism in a Sudanese family","volume":"10","author":"Bakhit","year":"2023","journal-title":"Annals of Clinical and Translational Neurology"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.parkreldis.2010.11.008","article-title":"Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson\u2019s disease","volume":"17","author":"Bardien","year":"2011","journal-title":"Parkinsonism & Related Disorders"},{"issue":"9","key":"10.1016\/j.arr.2026.103070_bib21","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1073\/pnas.0610548104","article-title":"Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson\u2019s disease","volume":"104","author":"Beasley","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"10.1016\/j.arr.2026.103070_bib22","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1212\/WNL.0000000000001332","article-title":"PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease","volume":"84","author":"Beecham","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1089\/nat.2023.0068","article-title":"Nucleic acid therapeutics: successes, milestones, and upcoming innovation","volume":"34","author":"Belgrad","year":"2024","journal-title":"Nucleic Acid Therapeutics"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib24","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1742-4658.2008.06301.x","article-title":"Parkinson\u2019s disease: a genetic perspective","volume":"275","author":"Belin","year":"2008","journal-title":"The FEBS Journal"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40478-021-01121-w","article-title":"Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson\u2019s disease","volume":"9","author":"BELNEU consortium","year":"2021","journal-title":"Acta Neuropathologica Communications"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuro.2012.02.001","article-title":"Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression","volume":"33","author":"Benskey","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.arr.2026.103070_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neulet.2017.08.040","article-title":"The GBA variant E326K is associated with Parkinson\u2019s disease and explains a genome-wide association signal","volume":"658","author":"Berge-Seidl","year":"2017","journal-title":"Neuroscience Letters"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mds.20343","article-title":"Novel parkin mutations detected in patients with early-onset Parkinson\u2019s disease","volume":"20","author":"Bertoli-Avella","year":"2005","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12035-012-8330-5","article-title":"\u03b1-Synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration","volume":"47","author":"Beyer","year":"2013","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.arr.2026.103070_bib30","doi-asserted-by":"crossref","first-page":"159.e5","DOI":"10.1016\/j.neurobiolaging.2017.12.012","article-title":"Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson\u2019s disease","volume":"64","author":"Blauwendraat","year":"2018","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.arr.2026.103070_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s13104-016-2102-7","article-title":"Clinical heterogeneity of PLA2G6-related Parkinsonism: Analysis of two Saudi families","volume":"9","author":"Bohlega","year":"2016","journal-title":"BMC Research Notes"},{"issue":"5604","key":"10.1016\/j.arr.2026.103070_bib32","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1212\/01.wnl.0000167546.39375.82","article-title":"Early-onset parkinsonism associated with PINK1 mutations: Frequency, genotypes, and phenotypes","volume":"65","author":"Bonifati","year":"2005","journal-title":"Neurology"},{"issue":"1\u20133","key":"10.1016\/j.arr.2026.103070_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbamcr.2003.08.008","article-title":"Roc, a Ras\/GTPase domain in complex proteins","volume":"1643","author":"Bosgraaf","year":"2003","journal-title":"Biochimica Et Biophysica Acta"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib35","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3233\/JPD-212566","article-title":"Effects of alpha-synuclein targeted antisense oligonucleotides on lewy body-like pathology and behavioral disturbances induced by injections of pre-formed fibrils in the mouse motor cortex","volume":"11","author":"Boutros","year":"2021","journal-title":"Journal of Parkinson\u2019s Disease"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib36","article-title":"Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson\u2019s disease (preclinical and clinical stages)","volume":"249","author":"Braak","year":"2002","journal-title":"Journal of Neurology"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/hmg\/ddn340","article-title":"Lack of replication of association between GIGYF2 variants and Parkinson disease","volume":"18","author":"Bras","year":"2009","journal-title":"Human Molecular Genetics"},{"issue":"11","key":"10.1016\/j.arr.2026.103070_bib38","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2010.281","article-title":"Recessively Inherited Parkinsonism: Effect of ATP13A2 Mutations on the Clinical and Neuroimaging Phenotype","volume":"67","author":"Br\u00fcggemann","year":"2010","journal-title":"Archives of Neurology"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10545-010-9055-0","article-title":"The risk of Parkinson\u2019s disease in type 1 Gaucher disease","volume":"33","author":"Bultron","year":"2010","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ymgme.2019.08.001","article-title":"Rare Saposin A deficiency: Novel variant and psychosine analysis","volume":"129","author":"Calderwood","year":"2020","journal-title":"Molecular Genetics and Metabolism"},{"issue":"49","key":"10.1016\/j.arr.2026.103070_bib41","doi-asserted-by":"crossref","first-page":"16544","DOI":"10.1523\/JNEUROSCI.1710-14.2014","article-title":"Upregulation of Parkin in endophilin mutant mice","volume":"34","author":"Cao","year":"2014","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"22","key":"10.1016\/j.arr.2026.103070_bib42","doi-asserted-by":"crossref","first-page":"12428","DOI":"10.1073\/pnas.2004335117","article-title":"Absence of Sac2\/INPP5F enhances the phenotype of a Parkinson\u2019s disease mutation of synaptojanin 1","volume":"117","author":"Cao","year":"2020","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib43","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.neuron.2017.01.019","article-title":"Parkinson Sac Domain Mutation in Synaptojanin 1 Impairs Clathrin Uncoating at Synapses and Triggers Dystrophic Changes in Dopaminergic Axons","volume":"93","author":"Cao","year":"2017","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.parkreldis.2006.12.002","article-title":"S18Y in ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) associated with decreased risk of Parkinson\u2019s disease in Sweden","volume":"13","author":"Carmine Belin","year":"2007","journal-title":"Parkinsonism & Related Disorders"},{"issue":"12","key":"10.1016\/j.arr.2026.103070_bib45","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1042\/BCJ20190342","article-title":"Molecular mechanism of Fast Endophilin-Mediated Endocytosis","volume":"477","author":"Casamento","year":"2020","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.arr.2026.103070_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109027","article-title":"Non-dopaminergic approaches to the treatment of motor complications in Parkinson\u2019s disease","volume":"210","author":"Cenci","year":"2022","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.arr.2026.103070_bib47","doi-asserted-by":"crossref","first-page":"2442.e5-9","DOI":"10.1016\/j.neurobiolaging.2013.04.028","article-title":"Association between PARK16 and Parkinson\u2019s disease in the Han Chinese population: A meta-analysis","volume":"34","author":"Chang","year":"2013","journal-title":"Neurobiology of Aging"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib48","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s13287-021-02585-2","article-title":"In vitro genome editing rescues parkinsonism phenotypes in induced pluripotent stem cells-derived dopaminergic neurons carrying LRRK2 p.G2019S mutation","volume":"12","author":"Chang","year":"2021","journal-title":"Stem Cell Research & Therapy"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib49","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awaa358","article-title":"Association analysis of PSAP variants in Parkinson\u2019s disease patients","volume":"144","author":"Chao","year":"2021","journal-title":"Brain: A Journal of Neurology"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib50","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ajhg.2011.08.009","article-title":"Translation initiator EIF4G1 mutations in familial Parkinson disease","volume":"89","author":"Chartier-Harlin","year":"2011","journal-title":"American Journal of Human Genetics"},{"issue":"9440","key":"10.1016\/j.arr.2026.103070_bib51","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet (London, England)"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib52","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/mds.27693","article-title":"LRP10 in autosomal-dominant Parkinson\u2019s disease","volume":"34","author":"Chen","year":"2019","journal-title":"Movement Disorders"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101392","article-title":"FBXO7 Y52C polymorphism as a potential protective factor in Parkinson\u2019s disease","volume":"9","author":"Chen","year":"2014","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib54","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s12035-020-02218-4","article-title":"Genetic Analysis of Prosaposin, the Lysosomal Storage Disorder Gene in Parkinson\u2019s Disease","volume":"58","author":"Chen","year":"2021","journal-title":"Molecular Neurobiology"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib55","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3390\/brainsci13040634","article-title":"Microglia and Astrocytes Dysfunction and Key Neuroinflammation-Based Biomarkers in Parkinson\u2019s Disease","volume":"13","author":"Chen","year":"2023","journal-title":"Brain Sciences"},{"issue":"16","key":"10.1016\/j.arr.2026.103070_bib56","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1212\/WNL.0000000000012705","article-title":"Neuropathologic Findings in a Patient With Juvenile-Onset Levodopa-Responsive Parkinsonism Due to ATP13A2 Mutation","volume":"97","author":"Chien","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2026.103070_bib57","article-title":"Pharmacological PINK1 activation ameliorates Pathology in Parkinson\u2019s Disease models","author":"Chin","year":"2023","journal-title":"bioRxiv: The Preprint Server for Biology"},{"issue":"45","key":"10.1016\/j.arr.2026.103070_bib58","doi-asserted-by":"crossref","first-page":"79046","DOI":"10.18632\/oncotarget.20893","article-title":"PARK14 PLA2G6 mutants are defective in preventing rotenone-induced mitochondrial dysfunction, ROS generation and activation of mitochondrial apoptotic pathway","volume":"8","author":"Chiu","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib59","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.febslet.2004.09.038","article-title":"Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein","volume":"576","author":"Choi","year":"2004","journal-title":"FEBS Letters"},{"key":"10.1016\/j.arr.2026.103070_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136288","article-title":"Mini-review: Synaptojanin 1 and its implications in membrane trafficking","volume":"765","author":"Choudhry","year":"2021","journal-title":"Neuroscience Letters"},{"issue":"12","key":"10.1016\/j.arr.2026.103070_bib61","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3390\/biom12121814","article-title":"Advances in Gene Therapy Techniques to Treat LRRK2 Gene Mutation","volume":"12","author":"Chung","year":"2022","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.arr.2026.103070_bib62","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm1001-1144","article-title":"Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: Implications for Lewy-body formation in Parkinson disease","volume":"7","author":"Chung","year":"2001","journal-title":"Nature Medicine"},{"key":"10.1016\/j.arr.2026.103070_bib63","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.REV120.014294","article-title":"Targeting mitophagy in Parkinson\u2019s disease","volume":"296","author":"Clark","year":"2021","journal-title":"The Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib64","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135633","article-title":"\u03b1-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson\u2019s disease","volume":"6","author":"Cole","year":"2021","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib65","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neulet.2010.10.015","article-title":"High cerebrospinal tau levels are associated with the rs242557 tau gene variant and low cerebrospinal \u03b2-amyloid in Parkinson disease","volume":"487","author":"Compta","year":"2011","journal-title":"Neuroscience Letters"},{"issue":"Pt 5","key":"10.1016\/j.arr.2026.103070_bib66","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awr031","article-title":"Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: Which is more important?","volume":"134","author":"Compta","year":"2011","journal-title":"Brain: A Journal of Neurology"},{"key":"10.1016\/j.arr.2026.103070_bib67","doi-asserted-by":"crossref","first-page":"192.e1","DOI":"10.1016\/j.neurobiolaging.2016.01.003","article-title":"FBXO7 mutations in Parkinson\u2019s disease and multiple system atrophy","volume":"40","author":"Conedera","year":"2016","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.arr.2026.103070_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105056","article-title":"VPS35 and the mitochondria: Connecting the dots in Parkinson\u2019s disease pathophysiology","volume":"145","author":"Cutillo","year":"2020","journal-title":"Neurobiology of Disease"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib69","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1471-4159.2010.07105.x","article-title":"Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant","volume":"116","author":"Dani\u00ebls","year":"2011","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.arr.2026.103070_bib70","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.parkreldis.2018.10.013","article-title":"PLA2G6-associated neurodegeneration: New insights into brain abnormalities and disease progression","volume":"61","author":"Darling","year":"2019","journal-title":"Parkinsonism & Related Disorders"},{"issue":"12","key":"10.1016\/j.arr.2026.103070_bib71","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/mds.27516","article-title":"Identification of a large homozygous VPS13C deletion in a patient with early-onset Parkinsonism","volume":"33","author":"Darvish","year":"2018","journal-title":"Movement Disorders"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib72","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1089\/ars.2015.6343","article-title":"Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson\u2019s Disease","volume":"24","author":"Deas","year":"2016","journal-title":"Antioxidants & Redox Signaling"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib73","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ng.3589","article-title":"Identification of TMEM230 mutations in familial Parkinson\u2019s disease","volume":"48","author":"Deng","year":"2016","journal-title":"Nature Genetics"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib74","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/ane.12397","article-title":"The EIF4G1 gene and Parkinson\u2019s disease","volume":"132","author":"Deng","year":"2015","journal-title":"Acta Neurologica Scandinavica"},{"issue":"11","key":"10.1016\/j.arr.2026.103070_bib75","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/jmedgenet-2018-105661","article-title":"Parkinson\u2019s disease GWAS-linked Park16 carriers show greater motor progression","volume":"56","author":"Deng","year":"2019","journal-title":"Journal of Medical Genetics"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib76","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00439-008-0526-4","article-title":"Replication of association between ELAVL4 and Parkinson disease: The GenePD study","volume":"124","author":"DeStefano","year":"2008","journal-title":"Human Genetics"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib77","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/339814","article-title":"PARK3 influences age at onset in Parkinson disease: A genome scan in the GenePD study","volume":"70","author":"DeStefano","year":"2002","journal-title":"American Journal of Human Genetics"},{"issue":"8","key":"10.1016\/j.arr.2026.103070_bib78","article-title":"A Review of the Regulatory Challenges of Personalized Medicine","volume":"16","author":"Dharani","year":"2024","journal-title":"Cureus"},{"issue":"19","key":"10.1016\/j.arr.2026.103070_bib79","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1212\/01.wnl.0000260963.08711.08","article-title":"ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease","volume":"68","author":"Di Fonzo","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib80","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1212\/01.wnl.0000338144.10967.2b","article-title":"FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome","volume":"72","author":"Di Fonzo","year":"2009","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib81","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The Role of Oxidative Stress in Parkinson\u2019s Disease","volume":"3","author":"Dias","year":"2013","journal-title":"Journal of Parkinson\u2019s Disease"},{"issue":"5866","key":"10.1016\/j.arr.2026.103070_bib82","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1126\/science.1152993","article-title":"Differential regulation of dynein and kinesin motor proteins by tau","volume":"319","author":"Dixit","year":"2008","journal-title":"Science (New York, N.Y.)"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib83","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4103\/1673-5374.300980","article-title":"Oxidative stress factors in Parkinson\u2019s disease","volume":"16","author":"Dorszewska","year":"2021","journal-title":"Neural Regeneration Research"},{"issue":"11","key":"10.1016\/j.arr.2026.103070_bib84","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1021\/bi101912q","article-title":"Coordination features and affinity of the Cu2+ site in the \u03b1-synuclein protein of Parkinson\u2019s disease","volume":"50","author":"Dudzik","year":"2011","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.arr.2026.103070_bib85","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/hmg\/ddr026","article-title":"Cyclin-G-associated kinase modifies \u03b1-synuclein expression levels and toxicity in Parkinson\u2019s disease: Results from the GenePD Study","volume":"20","author":"Dumitriu","year":"2011","journal-title":"Human Molecular Genetics"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib86","doi-asserted-by":"crossref","first-page":"1222.e1","DOI":"10.1016\/j.neurobiolaging.2014.09.005","article-title":"Homozygous nonsense mutation in SYNJ1 associated with intractable epilepsy and tau pathology","volume":"36","author":"Dyment","year":"2015","journal-title":"Neurobiology of Aging"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036458","article-title":"A Deleterious Mutation in DNAJC6 Encoding the Neuronal-Specific Clathrin-Uncoating Co-Chaperone Auxilin, Is Associated with Juvenile Parkinsonism","volume":"7","author":"Edvardson","year":"2012","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.arr.2026.103070_bib88","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1038\/s41591-024-03101-8","article-title":"Target engagement and immunogenicity of an active immunotherapeutic targeting pathological \u03b1-synuclein: A phase 1 placebo-controlled trial","volume":"30","author":"Eijsvogel","year":"2024","journal-title":"Nature Medicine"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib89","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ana.24591","article-title":"A Novel Nonsense Mutation in DNAJC6 Expands the Phenotype of Autosomal-Recessive Juvenile-Onset Parkinson\u2019s Disease","volume":"79","author":"Elsayed","year":"2016","journal-title":"Annals of Neurology"},{"issue":"9","key":"10.1016\/j.arr.2026.103070_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012897","article-title":"Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism","volume":"5","author":"Engel","year":"2010","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib91","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3233\/JPD-202138","article-title":"LRRK2 and the Endolysosomal System in Parkinson\u2019s Disease","volume":"10","author":"Erb","year":"2020","journal-title":"Journal of Parkinson\u2019s Disease"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib92","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/504728","article-title":"Genomewide association, Parkinson disease, and PARK10 [3]","volume":"78","author":"Farrer","year":"2006","journal-title":"American Journal of Human Genetics"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib93","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41419-018-0410-7","article-title":"Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations","volume":"9","author":"Fasano","year":"2018","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.arr.2026.103070_bib94","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3389\/fneur.2018.00536","article-title":"Heterozygous PLA2G6 Mutation Leads to Iron Accumulation Within Basal Ganglia and Parkinson\u2019s Disease","volume":"9","author":"Ferese","year":"2018","journal-title":"Frontiers in Neurology"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib95","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/brain\/awac326","article-title":"PTPA variants and impaired PP2A activity in early-onset parkinsonism with intellectual disability","volume":"146","author":"Fevga","year":"2023","journal-title":"Brain: A Journal of Neurology"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib96","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1080\/15548627.2022.2151294","article-title":"Substitution of PINK1 Gly411 modulates substrate receptivity and turnover","volume":"19","author":"Fiesel","year":"2023","journal-title":"Autophagy"},{"issue":"35","key":"10.1016\/j.arr.2026.103070_bib97","doi-asserted-by":"crossref","first-page":"18283","DOI":"10.1074\/jbc.M115.703157","article-title":"Parkinson Disease-linked Vps35 R524W Mutation Impairs the Endosomal Association of Retromer and Induces \u03b1-Synuclein Aggregation","volume":"291","author":"Follett","year":"2016","journal-title":"The Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib98","doi-asserted-by":"crossref","first-page":"935.e1-2","DOI":"10.1016\/j.neurobiolaging.2013.09.018","article-title":"DNAJ mutations are rare in Chinese Parkinson\u2019s disease patients and controls","volume":"35","author":"Foo","year":"2014","journal-title":"Neurobiology of Aging"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib99","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/brain\/awae365","article-title":"Lewy pathology formation in patient-derived GBA1 Parkinson\u2019s disease midbrain organoids","volume":"148","author":"Frattini","year":"2025","journal-title":"Brain: A Journal of Neurology"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib100","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"Alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nature Cell Biology"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib101","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.10113","article-title":"A new locus for Parkinson\u2019s disease (PARK8) maps to chromosome 12p11.2-q13.1","volume":"51","author":"Funayama","year":"2002","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib102","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1474-4422(14)70266-2","article-title":"CHCHD2 mutations in autosomal dominant late-onset Parkinson\u2019s disease: A genome-wide linkage and sequencing study","volume":"14","author":"Funayama","year":"2015","journal-title":"The Lancet. Neurology"},{"issue":"6369","key":"10.1016\/j.arr.2026.103070_bib103","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.aan6160","article-title":"Structural basis of membrane disruption and cellular toxicity by \u03b1-synuclein oligomers","volume":"358","author":"Fusco","year":"2017","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.arr.2026.103070_bib104","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.parkreldis.2018.06.004","article-title":"DNAJC13 mutation screening in patients with Parkinson\u2019s disease from South Italy","volume":"55","author":"Gagliardi","year":"2018","journal-title":"Parkinsonism & Related Disorders"},{"issue":"10","key":"10.1016\/j.arr.2026.103070_bib105","doi-asserted-by":"crossref","first-page":"2422.e1-2","DOI":"10.1016\/j.neurobiolaging.2014.04.020","article-title":"Frequency of the ASP620ASN mutation in VPS35 and Arg1205His mutation in EIF4G1 in familial Parkinson\u2019s disease from South Italy","volume":"35","author":"Gagliardi","year":"2014","journal-title":"Neurobiology of Aging"},{"issue":"12","key":"10.1016\/j.arr.2026.103070_bib106","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1038\/sj.emboj.7601174","article-title":"Mechanism of endophilin N-BAR domain-mediated membrane curvature","volume":"25","author":"Gallop","year":"2006","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.arr.2026.103070_bib107","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fnins.2016.00532","article-title":"Vacuolar Protein Sorting Genes in Parkinson\u2019s Disease: A Re-appraisal of Mutations Detection Rate and Neurobiology of Disease","volume":"10","author":"Gambardella","year":"2016","journal-title":"Frontiers in Neuroscience"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib108","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s12031-011-9641-0","article-title":"The age at motor symptoms onset in LRRK2-associated Parkinson\u2019s disease is affected by a variation in the MAPT locus: A possible interaction","volume":"46","author":"Gan-Or","year":"2012","journal-title":"Journal of Molecular Neuroscience: MN"},{"issue":"9","key":"10.1016\/j.arr.2026.103070_bib109","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13211","article-title":"Dependence of PINK1 accumulation on mitochondrial redox system","volume":"19","author":"Gao","year":"2020","journal-title":"Aging Cell"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib110","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jval.2016.02.012","article-title":"Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group","volume":"19","author":"Garfield","year":"2016","journal-title":"Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research"},{"issue":"23","key":"10.1016\/j.arr.2026.103070_bib111","doi-asserted-by":"crossref","first-page":"14821","DOI":"10.1021\/acs.jmedchem.0c01243","article-title":"Selective Inhibitors of G2019S-LRRK2 Kinase Activity","volume":"63","author":"Garofalo","year":"2020","journal-title":"Journal of Medicinal Chemistry"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib112","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ng0398-262","article-title":"A susceptibility locus for Parkinson\u2019s disease maps to chromosome 2p13","volume":"18","author":"Gasser","year":"1998","journal-title":"Nature Genetics"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib113","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13024-020-00367-7","article-title":"PINK1 and Parkin mitochondrial quality control: A source of regional vulnerability in Parkinson\u2019s disease","volume":"15","author":"Ge","year":"2020","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/j.arr.2026.103070_bib114","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.3389\/fneur.2019.01284","article-title":"The Role of Rare Coding Variants in Parkinson\u2019s Disease GWAS Loci","volume":"10","author":"Germer","year":"2019","journal-title":"Frontiers in Neurology"},{"issue":"23","key":"10.1016\/j.arr.2026.103070_bib115","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1093\/hmg\/ddp430","article-title":"GIGYF2 gene disruption in mice results in neurodegeneration and altered insulin-like growth factor signaling","volume":"18","author":"Giovannone","year":"2009","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.arr.2026.103070_bib116","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5334\/tohm.289","article-title":"PLA2G6 Mutations Related to Distinct Phenotypes: A New Case with Early-onset Parkinsonism","volume":"6","author":"Giri","year":"2016","journal-title":"Tremor and Other Hyperkinetic Movements (New York, N.Y."},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib117","first-page":"371","article-title":"PINK1: A Bridge between Mitochondria and Parkinson\u2019s Disease","volume":"11","author":"Gon\u00e7alves","year":"2021","journal-title":"Life (Basel, Switzerland)"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib118","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/ajmg.b.32454","article-title":"PARK16 is associated with PD in the Malaysian population","volume":"171","author":"Gopalai","year":"2016","journal-title":"American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib119","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1086\/504726","article-title":"No evidence for association with Parkinson disease for 13 single-nucleotide polymorphisms identified by whole-genome association screening","volume":"78","author":"Goris","year":"2006","journal-title":"American Journal of Human Genetics"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib120","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.3390\/ijms24032044","article-title":"GBA1 Gene Mutations in \u03b1-Synucleinopathies-Molecular Mechanisms Underlying Pathology and Their Clinical Significance","volume":"24","author":"Granek","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib121","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00401-021-02313-3","article-title":"LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson\u2019s disease and dementia with Lewy bodies","volume":"142","author":"Grochowska","year":"2021","journal-title":"Acta Neuropathologica"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib122","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1124\/pharmrev.120.000133","article-title":"Therapeutics in the Pipeline Targeting \u03b1-Synuclein for Parkinson\u2019s Disease","volume":"74","author":"Grosso Jasutkar","year":"2022","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.arr.2026.103070_bib123","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.878771","article-title":"Neuroinflammation in Parkinson\u2019s Disease\u2014Putative Pathomechanisms and Targets for Disease-Modification","volume":"13","author":"Grotemeyer","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"10.1016\/j.arr.2026.103070_bib124","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1007\/s00429-021-02359-9","article-title":"The effect of the PARK16 rs11240572 variant on brain structure in Parkinson\u2019s disease","volume":"226","author":"Gu","year":"2021","journal-title":"Brain Structure & Function"},{"key":"10.1016\/j.arr.2026.103070_bib125","doi-asserted-by":"crossref","first-page":"311.e1","DOI":"10.1016\/j.neurobiolaging.2020.05.005","article-title":"Mutation screening and burden analysis of VPS13C in Chinese patients with early-onset Parkinson\u2019s disease","volume":"94","author":"Gu","year":"2020","journal-title":"Neurobiology of Aging"},{"issue":"11","key":"10.1016\/j.arr.2026.103070_bib126","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.neurobiolaging.2009.12.016","article-title":"Mutational screening and zebrafish functional analysis of GIGYF2 as a Parkinson-disease gene","volume":"32","author":"Guella","year":"2011","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.arr.2026.103070_bib127","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.conb.2020.01.014","article-title":"New insights on the structure of alpha-synuclein fibrils using cryo-electron microscopy","volume":"61","author":"Guerrero-Ferreira","year":"2020","journal-title":"Current Opinion in Neurobiology"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib128","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S1474-4422(24)00121-2","article-title":"RAB32 Ser71Arg in autosomal dominant Parkinson\u2019s disease: Linkage, association, and functional analyses","volume":"23","author":"Gustavsson","year":"2024","journal-title":"The Lancet. Neurology"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib129","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mds.26064","article-title":"DNAJC13 genetic variants in parkinsonism","volume":"30","author":"Gustavsson","year":"2015","journal-title":"Movement Disorders"},{"key":"10.1016\/j.arr.2026.103070_bib130","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3389\/fgene.2019.01297","article-title":"Quality Control Strategy for CRISPR-Cas9-Based Gene Editing Complicated by a Pseudogene","volume":"10","author":"Hanss","year":"2019","journal-title":"Frontiers in Genetics"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib131","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/mds.28365","article-title":"Mitochondrial and Clearance Impairment in p.D620N VPS35 Patient-Derived Neurons","volume":"36","author":"Hanss","year":"2021","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib132","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/joim.13541","article-title":"Deep brain stimulation for Parkinson\u2019s disease","volume":"292","author":"Hariz","year":"2022","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.arr.2026.103070_bib133","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3389\/fnins.2017.00743","article-title":"DnaJ\/Hsp40 Family and Parkinson\u2019s Disease","volume":"11","author":"Hasegawa","year":"2018","journal-title":"Frontiers in Neuroscience"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib134","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.20251","article-title":"Novel PINK1 mutations in early-onset parkinsonism","volume":"56","author":"Hatano","year":"2004","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.arr.2026.103070_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129449","article-title":"Development of a highly potent and selective degrader of LRRK2","volume":"94","author":"Hatcher","year":"2023","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib136","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1006\/bbrc.1998.9134","article-title":"Point mutations (Thr240Arg and Gln311Stop) [correction of Thr240Arg and Ala311Stop] in the Parkin gene","volume":"249","author":"Hattori","year":"1998","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib137","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/mds.21336","article-title":"ELAVL4, PARK10, and the Celts","volume":"22","author":"Haugarvoll","year":"2007","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib138","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/ejhg.2008.187","article-title":"Fine-mapping and candidate gene investigation within the PARK10 locus","volume":"17","author":"Haugarvoll","year":"2009","journal-title":"European Journal of Human Genetics: EJHG"},{"issue":"16","key":"10.1016\/j.arr.2026.103070_bib139","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/hmg\/10.16.1649","article-title":"The importance of gene dosage studies: Mutational analysis of the parkin gene in early-onset parkinsonism","volume":"10","author":"Hedrich","year":"2001","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.arr.2026.103070_bib140","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2017.00177","article-title":"Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson\u2019s Disease","volume":"8","author":"Helley","year":"2017","journal-title":"Frontiers in Genetics"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib141","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.cell.2013.07.030","article-title":"A neo-substrate that amplifies catalytic activity of parkinson\u2019s-disease-related kinase PINK1","volume":"154","author":"Hertz","year":"2013","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib142","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/ana.10324","article-title":"A susceptibility gene for late-onset idiopathic Parkinson\u2019s disease","volume":"52","author":"Hicks","year":"2002","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.arr.2026.103070_bib143","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7917128","article-title":"G2385R and I2020T Mutations Increase LRRK2 GTPase Activity","volume":"2016","author":"Ho","year":"2016","journal-title":"BioMed Research International"},{"issue":"772","key":"10.1016\/j.arr.2026.103070_bib144","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.add7220","article-title":"Palmitoylation of the Parkinson\u2019s disease-associated protein synaptotagmin-11 links its turnover to \u03b1-synuclein homeostasis","volume":"16","author":"Ho","year":"2023","journal-title":"Science Signaling"},{"key":"10.1016\/j.arr.2026.103070_bib145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.parkreldis.2018.11.020","article-title":"Clonazepam improves the symptoms of two siblings with novel variants in the SYNJ1 gene","volume":"62","author":"Hong","year":"2019","journal-title":"Parkinsonism & Related Disorders"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib146","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s41588-024-01787-7","article-title":"Systematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson\u2019s disease","volume":"56","author":"Hop","year":"2024","journal-title":"Nature Genetics"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib147","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: Mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Human Mutation"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib148","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1096\/fj.201802031R","article-title":"The Parkinson\u2019s disease-associated mutation N1437H impairs conformational dynamics in the G domain of LRRK2","volume":"33","author":"Huang","year":"2019","journal-title":"FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib149","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209137","article-title":"Cinpanemab in Early Parkinson Disease: Evaluation of Biomarker Results From the Phase 2 SPARK Clinical Trial","volume":"102","author":"Hutchison","year":"2024","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib150","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1468-1331.2007.02012.x","article-title":"Lack of evidence for an association between UCHL1 S18Y and Parkinson\u2019s disease","volume":"15","author":"Hutter","year":"2008","journal-title":"European Journal of Neurology"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib151","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.molcel.2010.07.004","article-title":"UPF1 association with the cap-binding protein, CBP80, promotes nonsense-mediated mRNA decay at two distinct steps","volume":"39","author":"Hwang","year":"2010","journal-title":"Molecular Cell"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib152","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12883-017-0978-z","article-title":"Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels","volume":"17","author":"Ibanez","year":"2017","journal-title":"BMC Neurology"},{"issue":"10","key":"10.1016\/j.arr.2026.103070_bib153","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.1007\/s12010-023-04376-2","article-title":"Discovery of Small Molecule PARKIN Activator from Antipsychotic\/Anti-neuropsychiatric Drugs as Therapeutics for PD: An In Silico Repurposing Approach","volume":"195","author":"Ibrahim","year":"2023","journal-title":"Applied Biochemistry and Biotechnology"},{"key":"10.1016\/j.arr.2026.103070_bib154","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.10.018","article-title":"A novel mutation of CHCHD2 p.R8H in a sporadic case of Parkinson\u2019s disease","volume":"34","author":"Ikeda","year":"2017","journal-title":"Parkinsonism & Related Disorders"},{"issue":"15","key":"10.1016\/j.arr.2026.103070_bib155","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1093\/hmg\/ddx179","article-title":"Vps35 in cooperation with LRRK2 regulates synaptic vesicle endocytosis through the endosomal pathway in Drosophila","volume":"26","author":"Inoshita","year":"2017","journal-title":"Human Molecular Genetics"},{"issue":"15","key":"10.1016\/j.arr.2026.103070_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e35271","article-title":"Genetic and clinical study of PARK7 in Japanese Parkinson\u2019s disease","volume":"10","author":"Ishiguro","year":"2024","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib157","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3390\/biom13050845","article-title":"Overview of the Impact of Pathogenic LRRK2 Mutations in Parkinson\u2019s Disease","volume":"13","author":"Ito","year":"2023","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib158","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/mds.27974","article-title":"Penetrance of Parkinson\u2019s Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score","volume":"35","author":"Iwaki","year":"2020","journal-title":"Movement Disorders"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib159","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S1474-4422(15)00094-0","article-title":"CHCHD2 and Parkinson\u2019s disease","volume":"14","author":"Jansen","year":"2015","journal-title":"The Lancet. Neurology"},{"issue":"648","key":"10.1016\/j.arr.2026.103070_bib160","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj2658","article-title":"Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson\u2019s disease","volume":"14","author":"Jennings","year":"2022","journal-title":"Science Translational Medicine"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib161","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/mds.29297","article-title":"LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson\u2019s Disease","volume":"38","author":"Jennings","year":"2023","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib162","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12192-022-01273-1","article-title":"The mitochondria-targeted antioxidant MitoQ ameliorates myocardial ischemia-reperfusion injury by enhancing PINK1\/Parkin-mediated mitophagy in type 2 diabetic rats","volume":"27","author":"Ji","year":"2022","journal-title":"Cell Stress & Chaperones"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib163","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/genes13030471","article-title":"Monogenic Parkinson\u2019s Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing","volume":"13","author":"Jia","year":"2022","journal-title":"Genes"},{"issue":"19","key":"10.1016\/j.arr.2026.103070_bib164","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1093\/hmg\/ddz136","article-title":"Functionalization of the TMEM175 p.M393T variant as a risk factor for Parkinson disease","volume":"28","author":"Jinn","year":"2019","journal-title":"Human Molecular Genetics"},{"issue":"9","key":"10.1016\/j.arr.2026.103070_bib165","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1073\/pnas.1616332114","article-title":"TMEM175 deficiency impairs lysosomal and mitochondrial function and increases \u03b1-synuclein aggregation","volume":"114","author":"Jinn","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6959","key":"10.1016\/j.arr.2026.103070_bib166","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nature02052","article-title":"Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice","volume":"425","author":"Jones","year":"2003","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib167","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4161\/mabs.21696","article-title":"Fusion to a highly charged proteasomal retargeting sequence increases soluble cytoplasmic expression and efficacy of diverse anti-synuclein intrabodies","volume":"4","author":"Joshi","year":"2012","journal-title":"mAbs"},{"issue":"11","key":"10.1016\/j.arr.2026.103070_bib168","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/cmdc.201800100","article-title":"Niclosamide, a Drug with Many (Re)purposes","volume":"13","author":"Kadri","year":"2018","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib169","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/jamaneurol.2014.2704","article-title":"Clinical Correlations With Lewy Body Pathology in LRRK2 -Related Parkinson Disease","volume":"72","author":"Kalia","year":"2015","journal-title":"JAMA Neurology"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib170","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s13760-018-1003-z","article-title":"PLA2G6-related parkinsonism presenting as adolescent behavior","volume":"119","author":"Kamel","year":"2019","journal-title":"Acta Neurologica Belgica"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib171","first-page":"106","article-title":"Emergent glutamate & dopamine dysfunction in VPS35(D620N) knock-in mice and rapid reversal by LRRK2 inhibition. NPJ","volume":"11","author":"Kamesh","year":"2025","journal-title":"Parkinson\u2019s Disease"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib172","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12779","article-title":"The mitochondria-targeted anti-oxidant MitoQ protects against intervertebral disc degeneration by ameliorating mitochondrial dysfunction and redox imbalance","volume":"53","author":"Kang","year":"2020","journal-title":"Cell Proliferation"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib173","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155605","article-title":"Genetic Analysis of PLA2G6 in 22 Indian Families with Infantile Neuroaxonal Dystrophy, Atypical Late-Onset Neuroaxonal Dystrophy and Dystonia Parkinsonism Complex","volume":"11","author":"Kapoor","year":"2016","journal-title":"PloS One"},{"issue":"11","key":"10.1016\/j.arr.2026.103070_bib174","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1212\/01.WNL.0000095966.99430.F4","article-title":"A haplotype at the PARK3 locus influences onset age for Parkinson\u2019s disease: The GenePD study","volume":"61","author":"Karamohamed","year":"2003","journal-title":"Neurology"},{"issue":"20","key":"10.1016\/j.arr.2026.103070_bib175","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1038\/emboj.2009.257","article-title":"Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson\u2019s disease models","volume":"28","author":"Karpinar","year":"2009","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.arr.2026.103070_bib176","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1038\/srep04874","article-title":"The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson\u2019s disease","volume":"4","author":"Karuppagounder","year":"2014","journal-title":"Scientific Reports"},{"key":"10.1016\/j.arr.2026.103070_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2024.102000","article-title":"Mitochondria-targeted nanotherapeutics: A new frontier in neurodegenerative disease treatment","volume":"81","author":"Keethedeth","year":"2025","journal-title":"Mitochondrion"},{"issue":"32","key":"10.1016\/j.arr.2026.103070_bib178","doi-asserted-by":"crossref","first-page":"21856","DOI":"10.1074\/jbc.M114.553297","article-title":"The H50Q mutation enhances \u03b1-synuclein aggregation, secretion, and toxicity","volume":"289","author":"Khalaf","year":"2014","journal-title":"The Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib179","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1399-0004.2007.00781.x","article-title":"The Ala53Thr mutation in the alpha-synuclein gene in a Korean family with Parkinson disease","volume":"71","author":"Ki","year":"2007","journal-title":"Clinical Genetics"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib180","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00401-013-1096-7","article-title":"\u03b1-Synucleinopathy associated with G51D SNCA mutation: A link between Parkinson\u2019s disease and multiple system atrophy?","volume":"125","author":"Kiely","year":"2013","journal-title":"Acta Neuropathologica"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib181","first-page":"729","article-title":"The Parkinson\u2019s disease-linked protein TMEM230 is required for Rab8a-mediated secretory vesicle trafficking and retromer trafficking","volume":"26","author":"Kim","year":"2017","journal-title":"Human Molecular Genetics"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib182","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.parkreldis.2015.01.010","article-title":"Neuroimaging studies and whole exome sequencing of PLA2G6-associated neurodegeneration in a family with intrafamilial phenotypic heterogeneity","volume":"21","author":"Kim","year":"2015","journal-title":"Parkinsonism & Related Disorders"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib183","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.bbrc.2008.10.104","article-title":"PINK1 controls mitochondrial localization of Parkin through direct phosphorylation","volume":"377","author":"Kim","year":"2008","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.arr.2026.103070_bib184","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.parkreldis.2016.07.014","article-title":"Identification of a novel homozygous mutation Arg459Pro in SYNJ1 gene of an Indian family with autosomal recessive juvenile Parkinsonism","volume":"31","author":"Kirola","year":"2016","journal-title":"Parkinsonism & Related Disorders"},{"issue":"6676","key":"10.1016\/j.arr.2026.103070_bib185","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.arr.2026.103070_bib186","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1002\/mds.26814","article-title":"PLA2G6 mutations and Parkinsonism: Long-term follow-up of clinical features and neuropathology","volume":"31","author":"Klein","year":"2016","journal-title":"Movement Disorders"},{"issue":"Pt 4","key":"10.1016\/j.arr.2026.103070_bib187","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1469-1809.1999.6340285.x","article-title":"Search for the PARK3 founder haplotype in a large cohort of patients with Parkinson\u2019s disease from northern Germany","volume":"63","author":"Klein","year":"1999","journal-title":"Annals of Human Genetics"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib188","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/jlb\/lsx030","article-title":"Paving the road to personalized medicine: Recommendations on regulatory, intellectual property and reimbursement challenges","volume":"4","author":"Knowles","year":"2017","journal-title":"Journal of Law and the Biosciences"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib189","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s40258-021-00714-9","article-title":"Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options","volume":"20","author":"Koleva-Kolarova","year":"2022","journal-title":"Applied Health Economics and Health Policy"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib190","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.parkreldis.2012.11.006","article-title":"DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability","volume":"19","author":"K\u00f6ro\u011flu","year":"2013","journal-title":"Parkinsonism & Related Disorders"},{"issue":"11","key":"10.1016\/j.arr.2026.103070_bib191","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3390\/genes14112097","article-title":"The Landscape of Monogenic Parkinson\u2019s Disease in Populations of Non-European Ancestry: A Narrative Review","volume":"14","author":"Koros","year":"2023","journal-title":"Genes"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib192","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1212\/WNL.0000000000002361","article-title":"A nonsense mutation in CHCHD2 in a patient with Parkinson disease","volume":"86","author":"Koschmidder","year":"2016","journal-title":"Neurology"},{"issue":"7503","key":"10.1016\/j.arr.2026.103070_bib193","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nature13392","article-title":"Ubiquitin is phosphorylated by PINK1 to activate parkin","volume":"510","author":"Koyano","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103070_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2023.103125","article-title":"Generation of gene-corrected isogenic controls from Parkinson\u2019s disease patient iPSC lines carrying the pathogenic SNCA p.A53T variant","volume":"69","author":"Kozhushko","year":"2023","journal-title":"Stem Cell Research"},{"issue":"9","key":"10.1016\/j.arr.2026.103070_bib195","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/humu.22372","article-title":"The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures","volume":"34","author":"Krebs","year":"2013","journal-title":"Human Mutation"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib196","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.25629","article-title":"Genetic, Structural, and Functional Evidence Link TMEM175 to Synucleinopathies","volume":"87","author":"Krohn","year":"2020","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib197","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease","volume":"18","author":"Kr\u00fcger","year":"1998","journal-title":"Nature Genetics"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib198","doi-asserted-by":"crossref","first-page":"548.e9-18","DOI":"10.1016\/j.neurobiolaging.2009.11.021","article-title":"A large-scale genetic association study to evaluate the contribution of Omi\/HtrA2 (PARK13) to Parkinson\u2019s disease","volume":"32","author":"Kr\u00fcger","year":"2011","journal-title":"Neurobiology of Aging"},{"issue":"10","key":"10.1016\/j.arr.2026.103070_bib199","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/archneurol.2011.3367","article-title":"Frequency of the D620N mutation in VPS35 in Parkinson disease","volume":"69","author":"Kumar","year":"2012","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.arr.2026.103070_bib200","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.parkreldis.2020.07.014","article-title":"Novel and reported variants in Parkinson\u2019s disease genes confer high disease burden among Indians","volume":"78","author":"Kumar","year":"2020","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib201","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1038\/s41598-024-51646-y","article-title":"Prosaposin variants in sporadic, familial, and early-onset Parkinson\u2019s disease: A Taiwanese case\u2013control study and meta-analysis","volume":"14","author":"Kuo","year":"2024","journal-title":"Scientific Reports"},{"key":"10.1016\/j.arr.2026.103070_bib202","series-title":"GeneReviews\u00ae","article-title":"DNAJC6 Parkinson Disease","author":"Kurian","year":"1993"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib203","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa2203395","article-title":"Trial of Cinpanemab in Early Parkinson\u2019s Disease","volume":"387","author":"Lang","year":"2022","journal-title":"The New England Journal of Medicine"},{"issue":"4587","key":"10.1016\/j.arr.2026.103070_bib204","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science (New York, N.Y.)"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib205","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1523\/JNEUROSCI.0653-21.2021","article-title":"GCH1 Deficiency Activates Brain Innate Immune Response and Impairs Tyrosine Hydroxylase Homeostasis","volume":"42","author":"Larbalestier","year":"2022","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib206","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00441-017-2768-8","article-title":"The genetic architecture of mitochondrial dysfunction in Parkinson\u2019s disease","volume":"373","author":"Larsen","year":"2018","journal-title":"Cell and Tissue Research"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib207","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ajhg.2008.01.015","article-title":"Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease","volume":"82","author":"Lautier","year":"2008","journal-title":"American Journal of Human Genetics"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib208","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1083\/jcb.201210111","article-title":"PINK1 drives Parkin self-association and HECT-like E3 activity upstream of mitochondrial binding","volume":"200","author":"Lazarou","year":"2013","journal-title":"The Journal of Cell Biology"},{"issue":"7664","key":"10.1016\/j.arr.2026.103070_bib209","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature23269","article-title":"The lysosomal potassium channel TMEM175 adopts a novel tetrameric architecture","volume":"547","author":"Lee","year":"2017","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib210","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1091\/mbc.e07-11-1115","article-title":"Essential role of cyclin-G-associated kinase (Auxilin-2) in developing and mature mice","volume":"19","author":"Lee","year":"2008","journal-title":"Molecular Biology of the Cell"},{"issue":"6701","key":"10.1016\/j.arr.2026.103070_bib211","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","article-title":"The ubiquitin pathway in Parkinson\u2019s disease","volume":"395","author":"Leroy","year":"1998","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib212","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.23894","article-title":"G51D \u03b1-synuclein mutation causes a novel parkinsonian-pyramidal syndrome","volume":"73","author":"Lesage","year":"2013","journal-title":"Annals of Neurology"},{"issue":"9","key":"10.1016\/j.arr.2026.103070_bib213","doi-asserted-by":"crossref","first-page":"2233.e1","DOI":"10.1016\/j.neurobiolaging.2012.05.006","article-title":"EIF4G1 in familial Parkinson\u2019s disease: Pathogenic mutations or rare benign variants?","volume":"33","author":"Lesage","year":"2012","journal-title":"Neurobiology of Aging"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib214","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajhg.2016.01.014","article-title":"Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1\/Parkin-Dependent Mitophagy","volume":"98","author":"Lesage","year":"2016","journal-title":"The American Journal of Human Genetics"},{"key":"10.1016\/j.arr.2026.103070_bib215","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1016040","article-title":"Development of mutation-selective LRRK2 kinase inhibitors as precision medicine for Parkinson\u2019s disease and other diseases for which carriers are at increased risk","volume":"13","author":"Lesniak","year":"2022","journal-title":"Frontiers in Neurology"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib216","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbrc.2007.04.006","article-title":"The R1441C mutation of LRRK2 disrupts GTP hydrolysis","volume":"357","author":"Lewis","year":"2007","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"Pt 5","key":"10.1016\/j.arr.2026.103070_bib217","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1469-1809.2007.00353.x","article-title":"Investigation of the PARK10 gene in Parkinson disease","volume":"71","author":"Li","year":"2007","journal-title":"Annals of Human Genetics"},{"key":"10.1016\/j.arr.2026.103070_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2024.116350","article-title":"The mitochondria-targeted antioxidant MitoQ ameliorates inorganic arsenic-induced DCs\/Th1\/Th2\/Th17\/Treg differentiation partially by activating PINK1-mediated mitophagy in murine liver","volume":"277","author":"Li","year":"2024","journal-title":"Ecotoxicology and Environmental Safety"},{"issue":"11","key":"10.1016\/j.arr.2026.103070_bib219","doi-asserted-by":"crossref","DOI":"10.1177\/03000605241301877","article-title":"A novel homozygous PSAP mutation identified by whole exome sequencing in a consanguineous family with metachromatic leukodystrophy: A case report","volume":"52","author":"Li","year":"2024","journal-title":"The Journal of International Medical Research"},{"key":"10.1016\/j.arr.2026.103070_bib220","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.797833","article-title":"Mitochondrial Function and Parkinson\u2019s Disease: From the Perspective of the Electron Transport Chain","volume":"14","author":"Li","year":"2021","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib221","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/mds.29411","article-title":"Cross-Ethnic Variant Screening and Burden Analysis of PTPA in Parkinson\u2019s Disease","volume":"38","author":"Li","year":"2023","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib222","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/mds.27385","article-title":"Full sequencing and haplotype analysis of MAPT in Parkinson\u2019s disease and rapid eye movement sleep behavior disorder","volume":"33","author":"Li","year":"2018","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib223","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1086\/339815","article-title":"Age at Onset in Two Common Neurodegenerative Diseases Is Genetically Controlled","volume":"70","author":"Li","year":"2002","journal-title":"American Journal of Human Genetics"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib224","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1471-4159.2007.04743.x","article-title":"Leucine-rich repeat kinase 2 (LRRK2)\/PARK8 possesses GTPase activity that is altered in familial Parkinson\u2019s disease R1441C\/G mutants","volume":"103","author":"Li","year":"2007","journal-title":"Journal of Neurochemistry"},{"issue":"11","key":"10.1016\/j.arr.2026.103070_bib225","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1212\/01.WNL.0000164009.36740.4E","article-title":"Clinicogenetic study of PINK1 mutations in autosomal recessive early-onset parkinsonism","volume":"64","author":"Li","year":"2005","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.arr.2026.103070_bib226","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.3390\/ijms23084148","article-title":"Biomarker of Neuroinflammation in Parkinson\u2019s Disease","volume":"23","author":"Liu","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.arr.2026.103070_bib227","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2350-12-104","article-title":"Genome-Wide association study identifies candidate genes for Parkinson\u2019s disease in an Ashkenazi Jewish population","volume":"12","author":"Liu","year":"2011","journal-title":"BMC Medical Genetics"},{"issue":"37","key":"10.1016\/j.arr.2026.103070_bib228","doi-asserted-by":"crossref","first-page":"16930","DOI":"10.1021\/jacs.2c05499","article-title":"Discovery of XL01126: A Potent, Fast, Cooperative, Selective, Orally Bioavailable, and Blood-Brain Barrier Penetrant PROTAC Degrader of Leucine-Rich Repeat Kinase 2","volume":"144","author":"Liu","year":"2022","journal-title":"Journal of the American Chemical Society"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib229","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002537","article-title":"Parkinson\u2019s disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria","volume":"8","author":"Liu","year":"2012","journal-title":"PLoS Genetics"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib230","doi-asserted-by":"crossref","first-page":"8493","DOI":"10.1096\/fj.201903133RR","article-title":"CHCHD10-regulated OPA1-mitofilin complex mediates TDP-43-induced mitochondrial phenotypes associated with frontotemporal dementia","volume":"34","author":"Liu","year":"2020","journal-title":"FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib231","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3892\/etm.2024.12494","article-title":"Eukaryotic translation initiation factor EIF4G1 p.Ser637Cys mutation in a family with Parkinson\u2019s disease with antecedent essential tremor","volume":"27","author":"Liu","year":"2024","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"8","key":"10.1016\/j.arr.2026.103070_bib232","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/mds.26266","article-title":"A new F-box protein 7 gene mutation causing typical Parkinson\u2019s disease","volume":"30","author":"Lohmann","year":"2015","journal-title":"Movement Disorders"},{"issue":"9","key":"10.1016\/j.arr.2026.103070_bib233","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/ene.12770","article-title":"DNAJC13 p.Asn855Ser mutation screening in Parkinson\u2019s disease and pathologically confirmed Lewy body disease patients","volume":"22","author":"Lorenzo-Betancor","year":"2015","journal-title":"European Journal of Neurology"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib234","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/path.1711610210","article-title":"Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases","volume":"161","author":"Lowe","year":"1990","journal-title":"The Journal of Pathology"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib235","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s40120-025-00716-y","article-title":"A Multi-omics Framework Based on Machine Learning as a Predictor of Cognitive Impairment Progression in Early Parkinson\u2019s Disease","volume":"14","author":"Luo","year":"2025","journal-title":"Neurology and Therapy"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib236","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.neuron.2012.11.033","article-title":"RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson\u2019s disease risk","volume":"77","author":"MacLeod","year":"2013","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.arr.2026.103070_bib237","first-page":"804","article-title":"The Impact of SNCA Variations and Its Product Alpha-Synuclein on Non-Motor Features of Parkinson\u2019s Disease","volume":"11","author":"Magistrelli","year":"2021","journal-title":"Life (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib238","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/mds.28807","article-title":"Dissecting the Phenotype and Genotype of PLA2G6-Related Parkinsonism","volume":"37","author":"Magrinelli","year":"2022","journal-title":"Movement Disorders"},{"key":"10.1016\/j.arr.2026.103070_bib239","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-017-0099-z","article-title":"Current understanding of the molecular mechanisms in Parkinson\u2019s disease: Targets for potential treatments","volume":"6","author":"Maiti","year":"2017","journal-title":"Translational Neurodegeneration"},{"issue":"16","key":"10.1016\/j.arr.2026.103070_bib240","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1016\/j.febslet.2009.07.003","article-title":"Structure-activity relationship of amyloid fibrils","volume":"583","author":"Maji","year":"2009","journal-title":"FEBS Letters"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib241","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.parkreldis.2015.01.001","article-title":"A novel homozygous PLA2G6 mutation causes dystonia-parkinsonism","volume":"21","author":"Malaguti","year":"2015","journal-title":"Parkinsonism & Related Disorders"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib242","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1110\/ps.073411608","article-title":"Structural effects of Parkinson\u2019s disease linked DJ-1 mutations","volume":"17","author":"Malgieri","year":"2008","journal-title":"Protein Science: A Publication of the Protein Society"},{"issue":"21","key":"10.1016\/j.arr.2026.103070_bib243","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1093\/hmg\/ddv322","article-title":"VPS35 pathogenic mutations confer no dominant toxicity but partial loss of function in Drosophila and genetically interact with parkin","volume":"24","author":"Malik","year":"2015","journal-title":"Human Molecular Genetics"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib244","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1086\/496902","article-title":"High-resolution whole-genome association study of Parkinson disease","volume":"77","author":"Maraganore","year":"2005","journal-title":"American Journal of Human Genetics"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib245","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1212\/WNL.0000000000001708","article-title":"Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium","volume":"85","author":"Marder","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib246","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41531-020-00144-9","article-title":"Multimodal phenotypic axes of Parkinson\u2019s disease","volume":"7","author":"Markello","year":"2021","journal-title":"NPJ Parkinson\u2019s Disease"},{"issue":"22","key":"10.1016\/j.arr.2026.103070_bib247","doi-asserted-by":"crossref","first-page":"9848","DOI":"10.1128\/MCB.24.22.9848-9862.2004","article-title":"Neuroprotective Role of the Reaper-Related Serine Protease HtrA2\/Omi Revealed by Targeted Deletion in Mice","volume":"24","author":"Martins","year":"2004","journal-title":"Molecular and Cellular Biology"},{"issue":"49","key":"10.1016\/j.arr.2026.103070_bib248","doi-asserted-by":"crossref","first-page":"49417","DOI":"10.1074\/jbc.M308659200","article-title":"Binding specificity and regulation of the serine protease and PDZ domains of HtrA2\/Omi","volume":"278","author":"Martins","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.arr.2026.103070_bib249","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13024-015-0045-4","article-title":"The RAB39B p.G192R mutation causes X-linked dominant Parkinson\u2019s disease","volume":"10","author":"Mata","year":"2015","journal-title":"Molecular Neurodegeneration"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib250","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10048-005-0005-1","article-title":"Lrrk2 pathogenic substitutions in Parkinson\u2019s disease","volume":"6","author":"Mata","year":"2005","journal-title":"Neurogenetics"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib251","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1083\/jcb.200910140","article-title":"PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy","volume":"189","author":"Matsuda","year":"2010","journal-title":"The Journal of Cell Biology"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib252","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/BCJ20230492","article-title":"The Parkinson\u2019s disease related mutant VPS35 (D620N) amplifies the LRRK2 response to endolysosomal stress","volume":"481","author":"McCarron","year":"2024","journal-title":"The Biochemical Journal"},{"issue":"14","key":"10.1016\/j.arr.2026.103070_bib253","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.cub.2014.06.024","article-title":"Retromer binding to FAM21 and the WASH complex is perturbed by the Parkinson disease-linked VPS35(D620N) mutation","volume":"24","author":"McGough","year":"2014","journal-title":"Current Biology: CB"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib254","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13023-016-0436-9","article-title":"Utility of whole exome sequencing for the early diagnosis of pediatric-onset cerebellar atrophy associated with developmental delay in an inbred population","volume":"11","author":"Megahed","year":"2016","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib255","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1021\/acsmedchemlett.3c00070","article-title":"Parkinson\u2019s Disease: Are PINK1 Activators Inching Closer to the Clinic?","volume":"14","author":"Mehellou","year":"2023","journal-title":"ACS Medicinal Chemistry Letters"},{"issue":"11","key":"10.1016\/j.arr.2026.103070_bib256","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/mds.28218","article-title":"A Phase 1 Randomized Trial of Specific Active \u03b1-Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy","volume":"35","author":"Meissner","year":"2020","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib257","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3940(00)01510-X","article-title":"The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson\u2019s disease","volume":"293","author":"Mellick","year":"2000","journal-title":"Neuroscience Letters"},{"issue":"Pt 9","key":"10.1016\/j.arr.2026.103070_bib258","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1093\/brain\/awu179","article-title":"Parkinson\u2019s disease in GTP cyclohydrolase 1 mutation carriers","volume":"137","author":"Mencacci","year":"2014","journal-title":"Brain: A Journal of Neurology"},{"key":"10.1016\/j.arr.2026.103070_bib259","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108419","article-title":"Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues","volume":"246","author":"Menozzi","year":"2023","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.arr.2026.103070_bib260","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104619","article-title":"Optimizing intracellular antibodies (intrabodies\/nanobodies) to treat neurodegenerative disorders","volume":"134","author":"Messer","year":"2020","journal-title":"Neurobiology of Disease"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib261","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.3390\/ijms15034671","article-title":"Tau protein modifications and interactions: Their role in function and dysfunction","volume":"15","author":"Mietelska-Porowska","year":"2014","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.arr.2026.103070_bib262","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1038\/ncomms7504","article-title":"The intellectual disability protein RAB39B selectively regulates GluA2 trafficking to determine synaptic AMPAR composition","volume":"6","author":"Mignogna","year":"2015","journal-title":"Nature Communications"},{"key":"10.1016\/j.arr.2026.103070_bib263","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2019.04.029","article-title":"Therapeutic approaches to enhance PINK1\/Parkin mediated mitophagy for the treatment of Parkinson\u2019s disease","volume":"705","author":"Miller","year":"2019","journal-title":"Neuroscience Letters"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib264","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.neuron.2011.08.029","article-title":"Recruitment of endophilin to clathrin-coated pit necks is required for efficient vesicle uncoating after fission","volume":"72","author":"Milosevic","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2026.103070_bib265","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.parkreldis.2020.10.046","article-title":"Levodopa responsive-generalized dystonic spells and moaning in DNAJC6 related Juvenile Parkinson\u2019s disease","volume":"81","author":"Mittal","year":"2020","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/j.arr.2026.103070_bib266","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2377-12-62","article-title":"UCHL1 S18Y variant is a risk factor for Parkinson\u2019s disease in Japan","volume":"12","author":"Miyake","year":"2012","journal-title":"BMC Neurology"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib267","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s42003-022-03577-5","article-title":"Redefining GBA gene structure unveils the ability of Cap-independent, IRES-dependent gene regulation","volume":"5","author":"Miyoshi","year":"2022","journal-title":"Communications Biology"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib268","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ana.10079","article-title":"Association studies of multiple candidate genes for Parkinson\u2019s disease using single nucleotide polymorphisms","volume":"51","author":"Momose","year":"2002","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.arr.2026.103070_bib269","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.parkreldis.2021.11.031","article-title":"VPS13C-associated Parkinson\u2019s disease: Two novel cases and review of the literature","volume":"94","author":"Monfrini","year":"2022","journal-title":"Parkinsonism & Related Disorders"},{"issue":"9","key":"10.1016\/j.arr.2026.103070_bib270","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/13543776.2024.2378076","article-title":"Leucine-rich repeat kinase 2 (LRRK2) inhibitors for Parkinson\u2019s disease: A patent review of the literature to date","volume":"34","author":"Morez","year":"2024","journal-title":"Expert Opinion on Therapeutic Patents"},{"key":"10.1016\/j.arr.2026.103070_bib271","series-title":"GeneReviews\u00ae","article-title":"Monogenic Parkinson Disease Overview","author":"Morris","year":"1993"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib272","first-page":"E34","article-title":"Parkinson-related LRRK2 mutation R1441C\/G\/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3","volume":"111","author":"Muda","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib273","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamaneurol.2019.4611","article-title":"Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial","volume":"77","author":"Mullin","year":"2020","journal-title":"JAMA Neurology"},{"issue":"1\u20132","key":"10.1016\/j.arr.2026.103070_bib274","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3940(97)00710-6","article-title":"Identification of Spanish familial Parkinson\u2019s disease and screening for the Ala53Thr mutation of the alpha-synuclein gene in early onset patients","volume":"235","author":"Mu\u00f1oz","year":"1997","journal-title":"Neuroscience Letters"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib275","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/jnnp.73.5.582","article-title":"Relative high frequency of the c.255delA parkin gene mutation in Spanish patients with autosomal recessive parkinsonism","volume":"73","author":"Mu\u00f1oz","year":"2002","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib276","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13024-024-00766-0","article-title":"Gut-first Parkinson\u2019s disease is encoded by gut dysbiome","volume":"19","author":"Munoz-Pinto","year":"2024","journal-title":"Molecular Neurodegeneration"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib277","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1083\/jcb.201409064","article-title":"Sac2\/INPP5F is an inositol 4-phosphatase that functions in the endocytic pathway","volume":"209","author":"Nakatsu","year":"2015","journal-title":"The Journal of Cell Biology"},{"issue":"12","key":"10.1016\/j.arr.2026.103070_bib278","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: A meta-genome wide association study","volume":"18","author":"Nalls","year":"2019","journal-title":"The Lancet. Neurology"},{"issue":"9","key":"10.1016\/j.arr.2026.103070_bib279","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","article-title":"Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease","volume":"46","author":"Nalls","year":"2014","journal-title":"Nature Genetics"},{"issue":"8","key":"10.1016\/j.arr.2026.103070_bib280","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/mds.28063","article-title":"DNAJC6 Mutations Disrupt Dopamine Homeostasis in Juvenile Parkinsonism-Dystonia","volume":"35","author":"Ng","year":"2020","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib281","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1042\/BJ20091035","article-title":"Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson\u2019s disease","volume":"424","author":"Nichols","year":"2009","journal-title":"The Biochemical Journal"},{"issue":"22","key":"10.1016\/j.arr.2026.103070_bib282","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/01.wnl.0000346517.98982.1b","article-title":"Variation in GIGYF2 is not associated with Parkinson disease","volume":"72","author":"Nichols","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib283","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13024-025-00867-4","article-title":"Biomarkers and therapeutic strategies targeting microglia in neurodegenerative diseases: Current status and future directions","volume":"20","author":"Noh","year":"2025","journal-title":"Molecular Neurodegeneration"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib284","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12883-017-0933-z","article-title":"Early Onset Parkinson\u2019s Disease in a family of Moroccan origin caused by a p.A217D mutation in PINK1: A case report","volume":"17","author":"Norman","year":"2017","journal-title":"BMC Neurology"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib285","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00439-005-1259-2","article-title":"Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease","volume":"117","author":"Noureddine","year":"2005","journal-title":"Human Genetics"},{"issue":"11","key":"10.1016\/j.arr.2026.103070_bib286","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1212\/WNL.0b013e31828727d4","article-title":"Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease","volume":"80","author":"Nuytemans","year":"2013","journal-title":"Neurology"},{"issue":"4869","key":"10.1016\/j.arr.2026.103070_bib287","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.2842863","article-title":"Coding of two sphingolipid activator proteins (SAP-1 and SAP-2) by same genetic locus","volume":"241","author":"O\u2019Brien","year":"1988","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib288","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1038\/s41598-022-10789-6","article-title":"Mechanisms of enhanced aggregation and fibril formation of Parkinson\u2019s disease-related variants of \u03b1-synuclein","volume":"12","author":"Ohgita","year":"2022","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib289","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/brain\/awaa064","article-title":"Variants in saposin D domain of prosaposin gene linked to Parkinson\u2019s disease","volume":"143","author":"Oji","year":"2020","journal-title":"Brain: A Journal of Neurology"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib290","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10048-014-0406-0","article-title":"PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family","volume":"15","author":"Olgiati","year":"2014","journal-title":"Neurogenetics"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib291","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ana.24553","article-title":"DNAJC6 Mutations Associated With Early-Onset Parkinson\u2019s Disease","volume":"79","author":"Olgiati","year":"2016","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib292","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1086\/432588","article-title":"Identification of risk and age-at-onset genes on chromosome 1p in Parkinson disease","volume":"77","author":"Oliveira","year":"2005","journal-title":"American Journal of Human Genetics"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib293","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/ana.10524","article-title":"Parkin mutations and susceptibility alleles in late-onset Parkinson\u2019s disease","volume":"53","author":"Oliveira","year":"2003","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.arr.2026.103070_bib294","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1119736","article-title":"Health equity innovation in precision medicine: Current challenges and future directions","volume":"11","author":"Ory","year":"2023","journal-title":"Frontiers in Public Health"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib295","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-024-02886-y","article-title":"Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson\u2019s disease","volume":"30","author":"Pagano","year":"2024","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib296","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ana.21415","article-title":"Characterization of PLA2G6 as a locus for dystonia-parkinsonism","volume":"65","author":"Paisan-Ruiz","year":"2009","journal-title":"Annals of Neurology"},{"issue":"12","key":"10.1016\/j.arr.2026.103070_bib297","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/mds.23221","article-title":"Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations","volume":"25","author":"Pais\u00e1n-Ruiz","year":"2010","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib298","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease","volume":"44","author":"Pais\u00e1n-Ru\u00edz","year":"2004","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib299","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1086\/341282","article-title":"Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations","volume":"71","author":"Pankratz","year":"2002","journal-title":"American Journal of Human Genetics"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib300","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1086\/374383","article-title":"Significant linkage of Parkinson disease to chromosome 2q36-37","volume":"72","author":"Pankratz","year":"2003","journal-title":"American Journal of Human Genetics"},{"issue":"20","key":"10.1016\/j.arr.2026.103070_bib301","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/hmg\/ddg270","article-title":"Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families","volume":"12","author":"Pankratz","year":"2003","journal-title":"Human Molecular Genetics"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib302","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neulet.2006.09.003","article-title":"Mutations in DJ-1 are rare in familial Parkinson disease","volume":"408","author":"Pankratz","year":"2006","journal-title":"Neuroscience Letters"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib303","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11910-018-0829-3","article-title":"Mitochondrial Dysfunction in Parkinson\u2019s Disease: New Mechanistic Insights and Therapeutic Perspectives","volume":"18","author":"Park","year":"2018","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"8","key":"10.1016\/j.arr.2026.103070_bib304","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/humu.21527","article-title":"Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism","volume":"32","author":"Park","year":"2011","journal-title":"Human Mutation"},{"key":"10.1016\/j.arr.2026.103070_bib305","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.brainres.2007.10.061","article-title":"Complex I deficiency in Parkinson\u2019s disease frontal cortex","volume":"1189","author":"Parker","year":"2008","journal-title":"Brain Research"},{"issue":"10","key":"10.1016\/j.arr.2026.103070_bib306","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/mds.27136","article-title":"Cerebrospinal fluid \u03b2-glucocerebrosidase activity is reduced in parkinson\u2019s disease patients","volume":"32","author":"Parnetti","year":"2017","journal-title":"Movement Disorders"},{"issue":"9","key":"10.1016\/j.arr.2026.103070_bib307","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/mds.28665","article-title":"Potential PINK1 Founder Effect in Polynesia Causing Early-Onset Parkinson\u2019s Disease","volume":"36","author":"Patel","year":"2021","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib308","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1080\/15548627.2017.1385674","article-title":"Rilmenidine promotes MTOR-independent autophagy in the mutant SOD1 mouse model of amyotrophic lateral sclerosis without slowing disease progression","volume":"14","author":"Perera","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.arr.2026.103070_bib309","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105359","article-title":"Stimulation of mTOR-independent autophagy and mitophagy by rilmenidine exacerbates the phenotype of transgenic TDP-43 mice","volume":"154","author":"Perera","year":"2021","journal-title":"Neurobiology of Disease"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib310","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib311","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3940(00)01733-X","article-title":"A novel Cys212Tyr founder mutation in parkin and allelic heterogeneity of juvenile Parkinsonism in a population from North West Colombia","volume":"298","author":"Pineda-Trujillo","year":"2001","journal-title":"Neuroscience Letters"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib312","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40824-023-00381-y","article-title":"CRISPR\/Cas9 assisted stem cell therapy in Parkinson\u2019s disease","volume":"27","author":"Pinjala","year":"2023","journal-title":"Biomaterials Research"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib313","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039942","article-title":"Common pathogenic effects of missense mutations in the P-type ATPase ATP13A2 (PARK9) associated with early-onset parkinsonism","volume":"7","author":"Podhajska","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.arr.2026.103070_bib314","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nature Reviews. Disease Primers"},{"issue":"5321","key":"10.1016\/j.arr.2026.103070_bib315","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science (New York, N.Y.)"},{"issue":"11","key":"10.1016\/j.arr.2026.103070_bib316","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1212\/WNL.0b013e31828727ba","article-title":"A novel \u03b1-synuclein missense mutation in Parkinson disease","volume":"80","author":"Proukakis","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib317","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/brain\/aww261","article-title":"Heterozygous PINK1 p.G411S increases risk of Parkinson\u2019s disease via a dominant-negative mechanism","volume":"140","author":"Puschmann","year":"2017","journal-title":"Brain: A Journal of Neurology"},{"issue":"9","key":"10.1016\/j.arr.2026.103070_bib318","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/humu.22373","article-title":"Mutation in the SYNJ1 Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism","volume":"34","author":"Quadri","year":"2013","journal-title":"Human Mutation"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib319","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1474-4422(18)30179-0","article-title":"LRP10 genetic variants in familial Parkinson\u2019s disease and dementia with Lewy bodies: A genome-wide linkage and sequencing study","volume":"17","author":"Quadri","year":"2018","journal-title":"The Lancet. Neurology"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib320","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3390\/pharmaceutics14061252","article-title":"CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson\u2019s Disease","volume":"14","author":"Rahman","year":"2022","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib321","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/ejhg.2014.164","article-title":"VPS35 and DNAJC13 disease-causing variants in essential tremor","volume":"23","author":"Rajput","year":"2015","journal-title":"European Journal of Human Genetics: EJHG"},{"issue":"10","key":"10.1016\/j.arr.2026.103070_bib322","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ng1884","article-title":"Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase","volume":"38","author":"Ramirez","year":"2006","journal-title":"Nature Genetics"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib323","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.parkreldis.2010.09.002","article-title":"Association of Parkinson disease to PARK16 in a Chilean sample","volume":"17","author":"Ramirez","year":"2011","journal-title":"Parkinsonism and Related Disorders"},{"key":"10.1016\/j.arr.2026.103070_bib324","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2021.06.013","article-title":"DNAJC6 mutation causing cranial-onset dystonia with tremor dominant levodopa non-responsive parkinsonism: A novel phenotype","volume":"89","author":"Ray","year":"2021","journal-title":"Parkinsonism & Related Disorders"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib325","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00702-023-02623-8","article-title":"Clinical benefit of MAO-B and COMT inhibition in Parkinson\u2019s disease: Practical considerations","volume":"130","author":"Regensburger","year":"2023","journal-title":"Journal of Neural Transmission (Vienna, Austria: 1996)"},{"key":"10.1016\/j.arr.2026.103070_bib326","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1091919","article-title":"Association of GBA genotype with motor and cognitive decline in Chinese Parkinson\u2019s disease patients","volume":"15","author":"Ren","year":"2023","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib327","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JPD-212815","article-title":"A Practical Approach to Early-Onset Parkinsonism","volume":"12","author":"Riboldi","year":"2022","journal-title":"Journal of Parkinson\u2019s Disease"},{"issue":"13","key":"10.1016\/j.arr.2026.103070_bib328","first-page":"2645","article-title":"Glucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson\u2019s disease","volume":"25","author":"Rockenstein","year":"2016","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib329","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/ene.12552","article-title":"Infantile and childhood onset PLA2G6-associated neurodegeneration in a large North African cohort","volume":"22","author":"Romani","year":"2015","journal-title":"European Journal of Neurology"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib330","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11910-017-0737-y","article-title":"\u03b1-Synuclein and Parkinsonism: Updates and Future Perspectives","volume":"17","author":"Rosborough","year":"2017","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib331","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/hmg\/ddq428","article-title":"Molecular chaperone-mediated rescue of mitophagy by a Parkin RING1 domain mutant","volume":"20","author":"Rose","year":"2011","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.arr.2026.103070_bib332","doi-asserted-by":"crossref","first-page":"212.e13","DOI":"10.1016\/j.neurobiolaging.2016.04.023","article-title":"Analysis of DNAJC13 mutations in French-Canadian\/French cohort of Parkinson\u2019s disease","volume":"45","author":"Ross","year":"2016","journal-title":"Neurobiology of Aging"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib333","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.parkreldis.2008.08.003","article-title":"Genetic variation of Omi\/HtrA2 and Parkinson\u2019s disease","volume":"14","author":"Ross","year":"2008","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib334","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/mds.30141","article-title":"Classification and Genotype-Phenotype Relationships of GBA1 Variants: MDSGene Systematic Review","volume":"40","author":"Rossi","year":"2025","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib335","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tibs.2015.02.003","article-title":"Mitochondrial dysfunction and mitophagy in Parkinson\u2019s: From familial to sporadic disease","volume":"40","author":"Ryan","year":"2015","journal-title":"Trends in Biochemical Sciences"},{"issue":"Pt 3","key":"10.1016\/j.arr.2026.103070_bib336","article-title":"Therapeutic potential of Parkin and its regulation in Parkinson\u2019s disease","volume":"230","author":"Safreena","year":"2024","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.arr.2026.103070_bib337","doi-asserted-by":"crossref","first-page":"119.e7","DOI":"10.1016\/j.neurobiolaging.2020.10.019","article-title":"Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson\u2019s disease","volume":"100","author":"Saini","year":"2021","journal-title":"Neurobiology of Aging"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib338","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1468-1331.2009.02812.x","article-title":"Analysis of the GIGYF2 gene in familial and sporadic Parkinson disease in the Spanish population","volume":"17","author":"Samaranch","year":"2010","journal-title":"European Journal of Neurology"},{"issue":"Pt 4","key":"10.1016\/j.arr.2026.103070_bib339","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awq051","article-title":"PINK1-linked parkinsonism is associated with Lewy body pathology","volume":"133","author":"Samaranch","year":"2010","journal-title":"Brain: A Journal of Neurology"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib340","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/jcph.1096","article-title":"MAO-B and COMT Genetic Variations Associated With Levodopa Treatment Response in Patients With Parkinson\u2019s Disease","volume":"58","author":"Sampaio","year":"2018","journal-title":"Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib341","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40478-024-01766-3","article-title":"Effects of local reduction of endogenous \u03b1-synuclein using antisense oligonucleotides on the fibril-induced propagation of pathology through the neural network in wild-type mice","volume":"12","author":"Sano","year":"2024","journal-title":"Acta Neuropathologica Communications"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib342","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10048-010-0259-0","article-title":"Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability","volume":"12","author":"Santoro","year":"2011","journal-title":"Neurogenetics"},{"issue":"9","key":"10.1016\/j.arr.2026.103070_bib343","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1073\/pnas.1220464110","article-title":"Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies","volume":"110","author":"Sardi","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib344","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41531-020-00143-w","article-title":"Comparative proteomic analysis highlights metabolic dysfunction in \u03b1-synucleinopathy","volume":"6","author":"Sarkar","year":"2020","journal-title":"NPJ Parkinson\u2019s Disease"},{"issue":"12","key":"10.1016\/j.arr.2026.103070_bib345","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ng.485","article-title":"Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson\u2019s disease","volume":"41","author":"Satake","year":"2009","journal-title":"Nature Genetics"},{"issue":"1\u20132","key":"10.1016\/j.arr.2026.103070_bib346","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0022-510X(01)00555-X","article-title":"A polymorphic variation of serine to tyrosine at codon 18 in the ubiquitin C-terminal hydrolase-L1 gene is associated with a reduced risk of sporadic Parkinson\u2019s disease in a Japanese population","volume":"189","author":"Satoh","year":"2001","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib347","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1212\/WNL.57.3.560","article-title":"Lack of association between ubiquitin carboxy-terminal hydrolase L1 gene polymorphism and PD","volume":"57","author":"Savettieri","year":"2001","journal-title":"Neurology"},{"issue":"7143","key":"10.1016\/j.arr.2026.103070_bib348","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature05695","article-title":"Atomic structures of amyloid cross-beta spines reveal varied steric zippers","volume":"447","author":"Sawaya","year":"2007","journal-title":"Nature"},{"issue":"D1","key":"10.1016\/j.arr.2026.103070_bib349","doi-asserted-by":"crossref","first-page":"D20","DOI":"10.1093\/nar\/gkab1112","article-title":"Database resources of the national center for biotechnology information","volume":"50","author":"Sayers","year":"2022","journal-title":"Nucleic Acids Research"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib350","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson\u2019s disease","volume":"54","author":"Schapira","year":"1990","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib351","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/cge.13124","article-title":"Diagnostic exome sequencing in early-onset Parkinson\u2019s disease confirms VPS13C as a rare cause of autosomal-recessive Parkinson\u2019s disease","volume":"93","author":"Schormair","year":"2018","journal-title":"Clinical Genetics"},{"issue":"7683","key":"10.1016\/j.arr.2026.103070_bib352","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature24645","article-title":"Structure of PINK1 in complex with its substrate ubiquitin","volume":"552","author":"Schubert","year":"2017","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.arr.2026.103070_bib353","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1001\/jama.286.18.2239","article-title":"Complete genomic screen in Parkinson disease: Evidence for multiple genes","volume":"286","author":"Scott","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.arr.2026.103070_bib354","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.parkreldis.2019.11.015","article-title":"Autophagy lysosomal pathway dysfunction in Parkinson\u2019s disease; evidence from human genetics","volume":"73","author":"Senkevich","year":"2020","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/j.arr.2026.103070_bib355","article-title":"Are rare heterozygous SYNJ1 variants associated with Parkinson\u2019s disease?","author":"Senkevich","year":"2024","journal-title":"medRxiv: The Preprint Server for Health Sciences"},{"key":"10.1016\/j.arr.2026.103070_bib356","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jns.2016.02.014","article-title":"Synaptotagmin XI in Parkinson\u2019s disease: New evidence from an association study in Spain and Mexico","volume":"362","author":"Sesar","year":"2016","journal-title":"Journal of the Neurological Sciences"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib357","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nature Neuroscience"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib358","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/jmg.2005.039149","article-title":"The sepiapterin reductase gene region reveals association in the PARK3 locus: Analysis of familial and sporadic Parkinson\u2019s disease in European populations","volume":"43","author":"Sharma","year":"2006","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.arr.2026.103070_bib359","doi-asserted-by":"crossref","first-page":"217.e9","DOI":"10.1016\/j.neurobiolaging.2015.10.040","article-title":"CHCHD2 gene mutations in familial and sporadic Parkinson\u2019s disease","volume":"38","author":"Shi","year":"2016","journal-title":"Neurobiology of Aging"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib360","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1212\/WNL.0b013e318221acd3","article-title":"PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohort","volume":"77","author":"Shi","year":"2011","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.arr.2026.103070_bib361","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004861","article-title":"Phosphorylation of Mitochondrial Polyubiquitin by PINK1 Promotes Parkin Mitochondrial Tethering","volume":"10","author":"Shiba-Fukushima","year":"2014","journal-title":"PLoS Genetics"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib362","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.ajhg.2008.05.005","article-title":"Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays","volume":"82","author":"Shojaee","year":"2008","journal-title":"American Journal of Human Genetics"},{"issue":"17","key":"10.1016\/j.arr.2026.103070_bib363","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"The New England Journal of Medicine"},{"issue":"10","key":"10.1016\/j.arr.2026.103070_bib364","doi-asserted-by":"crossref","first-page":"2907.e13","DOI":"10.1016\/j.neurobiolaging.2015.07.008","article-title":"Variation in PARK10 is not associated with risk and age at onset of Parkinson\u2019s disease in large clinical cohorts","volume":"36","author":"Sim\u00f3n-S\u00e1nchez","year":"2015","journal-title":"Neurobiology of Aging"},{"issue":"12","key":"10.1016\/j.arr.2026.103070_bib365","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease","volume":"41","author":"Sim\u00f3n-S\u00e1nchez","year":"2009","journal-title":"Nature Genetics"},{"issue":"13","key":"10.1016\/j.arr.2026.103070_bib366","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/hmg\/ddn096","article-title":"Sequencing analysis of OMI\/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls","volume":"17","author":"Sim\u00f3n-S\u00e1nchez","year":"2008","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib367","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1468-1331.2008.02356.x","article-title":"R632W mutation in PLA2G6 segregates with dystonia-parkinsonism in a consanguineous Iranian family","volume":"16","author":"Sina","year":"2009","journal-title":"European Journal of Neurology"},{"issue":"5646","key":"10.1016\/j.arr.2026.103070_bib368","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"Alpha-Synuclein locus triplication causes Parkinson\u2019s disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science (New York, N.Y.)"},{"issue":"11","key":"10.1016\/j.arr.2026.103070_bib369","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.parkreldis.2014.08.019","article-title":"Early-onset Parkinson\u2019s disease due to PINK1 p.Q456X mutation\u2014Clinical and functional study","volume":"20","author":"Siuda","year":"2014","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib370","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/cells13040296","article-title":"Pathogenesis of DJ-1\/PARK7-Mediated Parkinson\u2019s Disease","volume":"13","author":"Skou","year":"2024","journal-title":"Cells"},{"issue":"13","key":"10.1016\/j.arr.2026.103070_bib371","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.3390\/ijms25137102","article-title":"GBA1-Associated Parkinson\u2019s Disease Is a Distinct Entity","volume":"25","author":"Skrahin","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib372","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40478-021-01121-w","article-title":"Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson\u2019s disease","volume":"9","author":"Smolders","year":"2021","journal-title":"Acta Neuropathologica Communications"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib373","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s40478-020-00935-4","article-title":"Genetic perspective on the synergistic connection between vesicular transport, lysosomal and mitochondrial pathways associated with Parkinson\u2019s disease pathogenesis","volume":"8","author":"Smolders","year":"2020","journal-title":"Acta Neuropathologica Communications"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib374","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.neuron.2016.09.037","article-title":"A LRRK2-Dependent EndophilinA Phosphoswitch Is Critical for Macroautophagy at Presynaptic Terminals","volume":"92","author":"Soukup","year":"2016","journal-title":"Neuron"},{"issue":"6645","key":"10.1016\/j.arr.2026.103070_bib375","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103070_bib376","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/ncomms2983","article-title":"A molecular explanation for the recessive nature of parkin-linked Parkinson\u2019s disease","volume":"4","author":"Spratt","year":"2013","journal-title":"Nature Communications"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib377","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/nat.2018.0736","article-title":"GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics","volume":"28","author":"Springer","year":"2018","journal-title":"Nucleic Acid Therapeutics"},{"issue":"34","key":"10.1016\/j.arr.2026.103070_bib378","doi-asserted-by":"crossref","first-page":"31469","DOI":"10.1074\/jbc.C300240200","article-title":"Inhibitor of apoptosis proteins are substrates for the mitochondrial serine protease Omi\/HtrA2","volume":"278","author":"Srinivasula","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"issue":"12","key":"10.1016\/j.arr.2026.103070_bib379","first-page":"2578","article-title":"The Analysis of Blood Inflammation Markers as Prognostic Factors in Parkinson\u2019s Disease","volume":"10","author":"Stanca","year":"2022","journal-title":"Healthcare (Basel, Switzerland)"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib380","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/jnnp-2020-322857","article-title":"Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson\u2019s disease","volume":"91","author":"Stoker","year":"2020","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"15","key":"10.1016\/j.arr.2026.103070_bib381","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/hmg\/ddi215","article-title":"Loss of function mutations in the gene encoding Omi\/HtrA2 in Parkinson\u2019s disease","volume":"14","author":"Strauss","year":"2005","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.arr.2026.103070_bib382","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease","volume":"106\u2013107","author":"Subramaniam","year":"2013","journal-title":"Progress in Neurobiology"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib383","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/archneur.63.6.826","article-title":"Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: The GenePD study","volume":"63","author":"Sun","year":"2006","journal-title":"Archives of Neurology"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib384","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1007\/s12035-017-0535-1","article-title":"A Clinical and Molecular Genetic Study of 50 Families with Autosomal Recessive Parkinsonism Revealed Known and Novel Gene Mutations","volume":"55","author":"Taghavi","year":"2018","journal-title":"Molecular Neurobiology"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib385","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2012.04.024","article-title":"The role of saposin C in Gaucher disease","volume":"106","author":"Tamargo","year":"2012","journal-title":"Molecular Genetics and Metabolism"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib386","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1212\/WNL.0b013e3181eccfcd","article-title":"Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus","volume":"75","author":"Tan","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib387","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00439-009-0678-x","article-title":"Non-synonymous GIGYF2 variants in Parkinson\u2019s disease from two Asian populations","volume":"126","author":"Tan","year":"2009","journal-title":"Human Genetics"},{"issue":"12","key":"10.1016\/j.arr.2026.103070_bib388","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.neurobiolaging.2008.11.008","article-title":"Analysis of the UCHL1 genetic variant in Parkinson\u2019s disease among Chinese","volume":"31","author":"Tan","year":"2010","journal-title":"Neurobiology of Aging"},{"issue":"10","key":"10.1016\/j.arr.2026.103070_bib389","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/mds.21064","article-title":"Case-control study of UCHL1 S18Y variant in Parkinson\u2019s disease","volume":"21","author":"Tan","year":"2006","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib390","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41531-023-00544-7","article-title":"Perspective on the current state of the LRRK2 field","volume":"9","author":"Taymans","year":"2023","journal-title":"NPJ Parkinson\u2019s Disease"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib391","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/15548627.2021.1888244","article-title":"Regulation of PRKN-independent mitophagy","volume":"18","author":"Tere\u0161ak","year":"2022","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib392","doi-asserted-by":"crossref","DOI":"10.1016\/j.crmeth.2024.100712","article-title":"Design and high-throughput implementation of MALDI-TOF\/MS-based assays for Parkin E3 ligase activity","volume":"4","author":"Traynor","year":"2024","journal-title":"Cell Reports Methods"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib393","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.molcel.2009.11.021","article-title":"SH3 domains from a subset of BAR proteins define a Ubl-binding domain and implicate parkin in synaptic ubiquitination","volume":"36","author":"Trempe","year":"2009","journal-title":"Molecular Cell"},{"issue":"6139","key":"10.1016\/j.arr.2026.103070_bib394","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.1237908","article-title":"Structure of parkin reveals mechanisms for ubiquitin ligase activation","volume":"340","author":"Trempe","year":"2013","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib395","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/bmb\/ldad035","article-title":"Genetics in Parkinson\u2019s disease, state-of-the-art and future perspectives","volume":"149","author":"Trevisan","year":"2024","journal-title":"British Medical Bulletin"},{"key":"10.1016\/j.arr.2026.103070_bib396","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/s41467-021-22108-0","article-title":"In situ architecture of neuronal \u03b1-Synuclein inclusions","volume":"12","author":"Trinkaus","year":"2021","journal-title":"Nature Communications"},{"issue":"17","key":"10.1016\/j.arr.2026.103070_bib397","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1093\/hmg\/ddu178","article-title":"Parkinson\u2019s disease-linked mutations in VPS35 induce dopaminergic neurodegeneration","volume":"23","author":"Tsika","year":"2014","journal-title":"Human Molecular Genetics"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib398","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.slasd.2022.12.004","article-title":"High-content phenotypic screen to identify small molecule enhancers of Parkin-dependent ubiquitination and mitophagy","volume":"28","author":"Tufi","year":"2023","journal-title":"SLAS Discovery: Advancing Life Sciences R & D"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib399","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nsmb.3194","article-title":"Solid-State NMR Structure of a Pathogenic Fibril of Full-Length Human \u03b1-Synuclein","volume":"23","author":"Tuttle","year":"2016","journal-title":"Nature Structural & Molecular Biology"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib400","doi-asserted-by":"crossref","first-page":"7567","DOI":"10.1038\/s41598-019-43772-9","article-title":"Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting \u03b1-synuclein as a novel therapy for Parkinson\u2019s disease","volume":"9","author":"Uehara","year":"2019","journal-title":"Scientific Reports"},{"issue":"1\u20133","key":"10.1016\/j.arr.2026.103070_bib401","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-5793(02)02446-8","article-title":"Accelerated alpha-synuclein fibrillation in crowded milieu","volume":"515","author":"Uversky","year":"2002","journal-title":"FEBS Letters"},{"issue":"5674","key":"10.1016\/j.arr.2026.103070_bib402","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib403","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/ana.10053","article-title":"PARK6-linked parkinsonism occurs in several European families","volume":"51","author":"Valente","year":"2002","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib404","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1086\/322996","article-title":"Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36","volume":"69","author":"van Duijn","year":"2001","journal-title":"American Journal of Human Genetics"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib405","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1212\/01.WNL.0000140494.58732.83","article-title":"POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement","volume":"63","author":"Van Goethem","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2026.103070_bib406","first-page":"7","article-title":"Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson\u2019s disease and other neurological disorders","author":"Van Veen","year":"2014","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"10","key":"10.1016\/j.arr.2026.103070_bib407","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.15252\/embj.201695773","article-title":"The SAC1 domain in synaptojanin is required for autophagosome maturation at presynaptic terminals","volume":"36","author":"Vanhauwaert","year":"2017","journal-title":"The EMBO Journal"},{"issue":"9","key":"10.1016\/j.arr.2026.103070_bib408","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00702-022-02531-3","article-title":"Glucocerebrosidase mutations and Parkinson disease","volume":"129","author":"Vieira","year":"2022","journal-title":"Journal of Neural Transmission"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib409","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/hmg\/ddt570","article-title":"DNAJC13 mutations in Parkinson disease","volume":"23","author":"Vilari\u00f1o-G\u00fcell","year":"2014","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib410","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2011.06.001","article-title":"VPS35 mutations in Parkinson disease","volume":"89","author":"Vilari\u00f1o-G\u00fcell","year":"2011","journal-title":"American Journal of Human Genetics"},{"issue":"14","key":"10.1016\/j.arr.2026.103070_bib411","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1021\/bi0121353","article-title":"Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson\u2019s disease-linked mutations and occurs by a pore-like mechanism","volume":"41","author":"Volles","year":"2002","journal-title":"Biochemistry"},{"issue":"26","key":"10.1016\/j.arr.2026.103070_bib412","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1021\/bi030086j","article-title":"Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson\u2019s disease","volume":"42","author":"Volles","year":"2003","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib413","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.parkreldis.2013.10.001","article-title":"Association mapping of the PARK10 region for Parkinson\u2019s disease susceptibility genes","volume":"20","author":"Wan","year":"2014","journal-title":"Parkinsonism & Related Disorders"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib414","first-page":"1853","article-title":"Downregulation of ATP13A2 in midbrain dopaminergic neurons is related to defective autophagy in a mouse model of Parkinson\u2019s disease","volume":"13","author":"Wan","year":"2020","journal-title":"International Journal of Clinical and Experimental Pathology"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib415","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archneur.65.4.467","article-title":"Risk of Parkinson\u2019s Disease in Carriers of Parkin mutations: Estimation Using the Kin-Cohort Method","volume":"65","author":"Wang","year":"2008","journal-title":"Archives of Neurology"},{"issue":"12","key":"10.1016\/j.arr.2026.103070_bib416","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.jocn.2011.05.014","article-title":"Follow-up study of variants of the GIGYF2 gene in Chinese patients with Parkinson\u2019s disease","volume":"18","author":"Wang","year":"2011","journal-title":"Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia"},{"key":"10.1016\/j.arr.2026.103070_bib417","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target","volume":"4","author":"Wang","year":"2015","journal-title":"Translational Neurodegeneration"},{"issue":"9","key":"10.1016\/j.arr.2026.103070_bib418","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/jcmm.17704","article-title":"Increased level of RAB39B leads to neuronal dysfunction and behavioural changes in mice","volume":"27","author":"Wang","year":"2023","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib419","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm.3983","article-title":"Parkinson\u2019s disease\u2013associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes","volume":"22","author":"Wang","year":"2016","journal-title":"Nature Medicine"},{"key":"10.1016\/j.arr.2026.103070_bib420","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.brainres.2011.02.037","article-title":"Genetic variations of Omi\/HTRA2 in Chinese patients with Parkinson\u2019s disease","volume":"1385","author":"Wang","year":"2011","journal-title":"Brain Research"},{"key":"10.1016\/j.arr.2026.103070_bib421","article-title":"Genetic analysis of dystonia-related genes in Parkinson\u2019s disease","volume":"15","author":"Wang","year":"2023","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"7479","key":"10.1016\/j.arr.2026.103070_bib422","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature12809","article-title":"Ultrafast endocytosis at mouse hippocampal synapses","volume":"504","author":"Watanabe","year":"2013","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.arr.2026.103070_bib423","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1038\/emboj.2013.125","article-title":"Structure of the human Parkin ligase domain in an autoinhibited state","volume":"32","author":"Wauer","year":"2013","journal-title":"The EMBO Journal"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib424","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/ijms20010147","article-title":"Roco Proteins: GTPases with a Baroque Structure and Mechanism","volume":"20","author":"Wauters","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib425","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1042\/BJ20110293","article-title":"Tetrahydrobiopterin: Biochemistry and pathophysiology","volume":"438","author":"Werner","year":"2011","journal-title":"The Biochemical Journal"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib426","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mds.28858","article-title":"Parkinson\u2019s Disease Modification Through Abl Kinase Inhibition: An Opportunity","volume":"37","author":"Werner","year":"2022","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib427","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.26075","article-title":"Ten years and counting: Moving leucine-rich repeat kinase 2 inhibitors to the clinic","volume":"30","author":"West","year":"2015","journal-title":"Movement Disorders"},{"issue":"46","key":"10.1016\/j.arr.2026.103070_bib428","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1073\/pnas.0507360102","article-title":"Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity","volume":"102","author":"West","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"9","key":"10.1016\/j.arr.2026.103070_bib429","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.ejhg.5200698","article-title":"Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes","volume":"9","author":"West","year":"2001","journal-title":"European Journal of Human Genetics: EJHG"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib430","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3233\/JPD-161020","article-title":"VPS35, the Retromer Complex and Parkinson\u2019s Disease","volume":"7","author":"Williams","year":"2017","journal-title":"Journal of Parkinson\u2019s Disease"},{"key":"10.1016\/j.arr.2026.103070_bib431","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105768","article-title":"Understanding the contributions of VPS35 and the retromer in neurodegenerative disease","volume":"170","author":"Williams","year":"2022","journal-title":"Neurobiology of Disease"},{"issue":"11","key":"10.1016\/j.arr.2026.103070_bib432","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","article-title":"The CamPaIGN study of Parkinson\u2019s disease: 10-year outlook in an incident population-based cohort","volume":"84","author":"Williams-Gray","year":"2013","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"16","key":"10.1016\/j.arr.2026.103070_bib433","doi-asserted-by":"crossref","first-page":"9256","DOI":"10.1073\/pnas.1133288100","article-title":"The 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson\u2019s disease","volume":"100","author":"Wilson","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib434","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ajhg.2014.10.015","article-title":"Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with \u03b1-synuclein pathology","volume":"95","author":"Wilson","year":"2014","journal-title":"American Journal of Human Genetics"},{"issue":"10","key":"10.1016\/j.arr.2026.103070_bib435","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1097\/00001756-200007140-00004","article-title":"Mutation analysis and association studies of the UCHL1 gene in German Parkinson\u2019s disease patients","volume":"11","author":"Wintermeyer","year":"2000","journal-title":"Neuroreport"},{"issue":"9","key":"10.1016\/j.arr.2026.103070_bib436","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1111\/ene.15893","article-title":"Parkinson\u2019s disease genome-wide association study-linked PARK16 variant is associated with a lower risk of cognitive impairment: A 4-year observational study","volume":"30","author":"Xiao","year":"2023","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.arr.2026.103070_bib437","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.parkreldis.2019.11.001","article-title":"A novel homozygous SYNJ1 mutation in two siblings with typical Parkinson\u2019s disease","volume":"69","author":"Xie","year":"2019","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/j.arr.2026.103070_bib438","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neulet.2013.02.031","article-title":"Genetic analysis of the FBXO48 gene in Chinese Han patients with Parkinson disease","volume":"541","author":"Xiu","year":"2013","journal-title":"Neuroscience Letters"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib439","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.3390\/ijms24076338","article-title":"Genetic Evidence for Endolysosomal Dysfunction in Parkinson\u2019s Disease: A Critical Overview","volume":"24","author":"Yahya","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"11","key":"10.1016\/j.arr.2026.103070_bib440","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.parkreldis.2014.06.024","article-title":"A new Turkish family with homozygous FBXO7 truncating mutation and juvenile atypical parkinsonism","volume":"20","author":"Yalcin-Cakmakli","year":"2014","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib441","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00702-016-1658-7","article-title":"Mutation screening of PLA2G6 in Japanese patients with early onset dystonia-parkinsonism","volume":"124","author":"Yamashita","year":"2017","journal-title":"Journal of Neural Transmission (Vienna, Austria: 1996)"},{"issue":"10","key":"10.1016\/j.arr.2026.103070_bib442","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.parkreldis.2011.07.012","article-title":"An association between the PARK16 locus and Parkinson\u2019s disease in a cohort from eastern China","volume":"17","author":"Yan","year":"2011","journal-title":"Parkinsonism & Related Disorders"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib443","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0888-7543(95)80227-D","article-title":"Human protein synthesis initiation factor eIF-4 gamma is encoded by a single gene (EIF4G) that maps to chromosome 3q27-qter","volume":"26","author":"Yan","year":"1995","journal-title":"Genomics"},{"issue":"18","key":"10.1016\/j.arr.2026.103070_bib444","article-title":"NMR unveils an N-terminal interaction interface on acetylated-\u03b1-synuclein monomers for recruitment to fibrils","volume":"118","author":"Yang","year":"2021","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.arr.2026.103070_bib445","doi-asserted-by":"crossref","first-page":"215.e1","DOI":"10.1016\/j.neurobiolaging.2018.11.012","article-title":"Systematically analyzing rare variants of autosomal-dominant genes for sporadic Parkinson\u2019s disease in a Chinese cohort","volume":"76","author":"Yang","year":"2019","journal-title":"Neurobiology of Aging"},{"issue":"9","key":"10.1016\/j.arr.2026.103070_bib446","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1073\/pnas.1000738107","article-title":"Endocytosis and clathrin-uncoating defects at synapses of auxilin knockout mice","volume":"107","author":"Yim","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib447","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/crispr.2021.0025","article-title":"CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson\u2019s Disease In Vivo","volume":"5","author":"Yoon","year":"2022","journal-title":"The CRISPR Journal"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib448","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/hmg\/ddy003","article-title":"Parkinson\u2019s disease-linked DNAJC13 mutation aggravates alpha-synuclein-induced neurotoxicity through perturbation of endosomal trafficking","volume":"27","author":"Yoshida","year":"2018","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib449","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ensci.2015.08.001","article-title":"Interaction between SNCA, LRRK2 and GAK increases susceptibility to Parkinson\u2019s disease in a Chinese population","volume":"1","author":"Yu","year":"2015","journal-title":"eNeurologicalSci"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib450","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/acn3.509","article-title":"Combining clinical and biofluid markers for early Parkinson\u2019s disease detection","volume":"5","author":"Yu","year":"2018","journal-title":"Annals of Clinical and Translational Neurology"},{"issue":"9095","key":"10.1016\/j.arr.2026.103070_bib451","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(05)78089-2","article-title":"Analysis of the alpha-synuclein G209A mutation in familial Parkinson\u2019s disease","volume":"351","author":"Zareparsi","year":"1998","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib452","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.arr.2026.103070_bib453","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1038\/ncomms4828","article-title":"Mutation in VPS35 associated with Parkinson\u2019s disease impairs WASH complex association and inhibits autophagy","volume":"5","author":"Zavodszky","year":"2014","journal-title":"Nature Communications"},{"issue":"5","key":"10.1016\/j.arr.2026.103070_bib454","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s40273-025-01474-3","article-title":"Innovative Payment Models for Sickle-Cell Disease Gene Therapies in Medicaid: Leveraging Real-World Data and Insights from CMMI\u2019s Gene Therapy Access Model","volume":"43","author":"Zemplenyi","year":"2025","journal-title":"PharmacoEconomics"},{"issue":"3","key":"10.1016\/j.arr.2026.103070_bib455","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neulet.2008.07.012","article-title":"Lack of evidence for association of a UCH-L1 S18Y polymorphism with Parkinson\u2019s disease in a Han-Chinese population","volume":"442","author":"Zhang","year":"2008","journal-title":"Neuroscience Letters"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib456","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1468-1331.2012.03856.x","article-title":"Follow-up study of 25 Chinese children with PLA2G6-associated neurodegeneration","volume":"20","author":"Zhang","year":"2013","journal-title":"European Journal of Neurology"},{"issue":"16","key":"10.1016\/j.arr.2026.103070_bib457","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.cub.2014.07.014","article-title":"PINK1 triggers autocatalytic activation of Parkin to specify cell fate decisions","volume":"24","author":"Zhang","year":"2014","journal-title":"Current Biology: CB"},{"issue":"11","key":"10.1016\/j.arr.2026.103070_bib458","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s10072-015-2316-9","article-title":"The contribution of GIGYF2 to Parkinson\u2019s disease: A meta-analysis","volume":"36","author":"Zhang","year":"2015","journal-title":"Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"2","key":"10.1016\/j.arr.2026.103070_bib459","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016983","article-title":"Loss of nuclear activity of the FBXO7 protein in patients with parkinsonian-pyramidal syndrome (PARK15)","volume":"6","author":"Zhao","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.arr.2026.103070_bib460","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.omtn.2017.08.002","article-title":"LRRK2 Antisense Oligonucleotides Ameliorate \u03b1-Synuclein Inclusion Formation in a Parkinson\u2019s Disease Mouse Model","volume":"8","author":"Zhao","year":"2017","journal-title":"Molecular Therapy. Nucleic Acids"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib461","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/NEN.0b013e318293c586","article-title":"FBXO7 immunoreactivity in \u03b1-synuclein-containing inclusions in Parkinson disease and multiple system atrophy","volume":"72","author":"Zhao","year":"2013","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib462","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41421-023-00639-8","article-title":"Pharmacology of LRRK2 with type I and II kinase inhibitors revealed by cryo-EM","volume":"10","author":"Zhu","year":"2024","journal-title":"Cell Discovery"},{"issue":"6","key":"10.1016\/j.arr.2026.103070_bib463","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/brain\/awab456","article-title":"Heterozygous PRKN mutations are common but do not increase the risk of Parkinson\u2019s disease","volume":"145","author":"Zhu","year":"2022","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.arr.2026.103070_bib464","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ajhg.2011.06.008","article-title":"A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease","volume":"89","author":"Zimprich","year":"2011","journal-title":"The American Journal of Human Genetics"},{"issue":"4","key":"10.1016\/j.arr.2026.103070_bib465","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.arr.2026.103070_bib466","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.parkreldis.2009.01.005","article-title":"PARK11 gene (GIGYF2) variants Asn56Ser and Asn457Thr are not pathogenic for Parkinson\u2019s disease","volume":"15","author":"Zimprich","year":"2009","journal-title":"Parkinsonism & Related Disorders"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726000620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726000620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:08:18Z","timestamp":1778821698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163726000620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":466,"alternative-id":["S1568163726000620"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2026.103070","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An update on the monogenic causes of Parkinson\u2019s disease: Impact on patient stratification and personalised medicine","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2026.103070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103070"}}